Top

Jonathan L Curry, M.D.

Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

About Dr. Jonathan L Curry

I am board certified in anatomic and clinical pathology with subspecialty board certification in dermatopathology. My current position is a Professor in the Department of Pathology, Translational Molecular Pathology, and Dermatology at MD Anderson Cancer Center. My main research interests center on adverse cutaneous reactions from targeted and immune checkpoint inhibitor cancer therapy. My research focus is to investigate the role of the skin microbiome and the immunopathogenesis that drives these cutaneous irAEs in genetically susceptible patients.

We demonstrated lichenoid skin toxicities from immune checkpoint inhibitor therapy displays differentially expressed genes related to recruitment of CD14⁺ and CD16⁺ monocytes and Toll-like receptors (TLRs) activation. We have proposed an innate immune response activation and mechanism of augmented TLRs response to patient’s unique skin microbiome in lichenoid skin toxicities. I have presented at national and international institutions and meetings on the cutaneous toxicities and I have provided my clinical expertise to the dermatopathology diagnoses worldwide.

Primary Appointment

Professor, Department of Pathology, Division of Pathology/Lab Medicine, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

Professor, Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

Research Interests

My research interests have been in melanoma and cutaneous toxicities to melanoma therapy. Our group was the first to characterize mitosis-associated dual histone, H3K79me3/T80ph in melanoma and demonstrated this histone significantly identified a subset of cutaneous melanomas with metastatic potential. We have also examined senescence functions as tumor suppressor mechanism in melanocytes. We have published that histone deacetylase 1 (HDAC1) is a mediator of early chromatin-remodeling events in senescence of melanocytes and also identified the cyclin-dependent kinase inhibitor p57^KIP2 likely contributes to melanocyte senescence and the development of nevi.

My current research efforts are centered on cutaneous toxicities to novel cancer therapy. Our group reported on the spectrum of skin toxicities that may manifest from targeted therapy and characterized changing melanocytic lesions in patients treated with BRAF inhibitor. We published these nevi demonstrate increase cell cyclin levels and do not harbor BRAFV600E mutation. This study was selected for the journal cover of Human Pathology. We published on the diverse array of cutaneous toxicities that may manifest in patients receiving immune checkpoint antibody therapy including immunobullous, granulomatous/sarcoid, and lichenoid reactions. Our lichenoid skin toxicity study was selected for the cover of the American Journal of Dermatopathology. Our group is leading the field in investigating the immune mechanisms of cutaneous immune-related adverse events (irAE) and our work has identified a role of monocytes in lichenoid dermatitis

Our studies have identified activation of the innate immune response in LD-ICI and a possible role of CD14/TLR signaling and cutaneous microbiome. This work provided some insight into the immunopathogenesis of cutaneous irAEs and immune mechanisms driving these reactions.

Clinical Interests

My clinical interest is in the dermatological health in patients treated at MD Anderson and I provide expert pathologic diagnosis of neoplastic and inflammatory skin disorders. I provide clinical expertise in evaluating melanoma and melanocytic lesions, cutaneous cancers, and a variety of inflammatory dermatitides. I also provide dermatopathology expertise in adverse cutaneous reactions to novel anti-cancer therapy.

Education & Training

Degree-Granting Education

1998	Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, US, MD
1993	Northeast Missouri State University, Kirksville, Missouri, US, BS in Science

Postgraduate Training

2003-2004	Clinical Fellowship, Dermatopathology, Baylor College of Medicine, Houston, Texas
2001-2002	Research Fellowship, Skin Disease Research Laboratory, Loyola University Medical Center, Maywood, Illinois
1998-2003	Clinical Residency, Anatomic and Clinical Pathology, Loyola University Medical Center, Maywood, Illinois

Licenses & Certifications

2004	American Board of Pathology and Dermatology
2004	Texas Medical License
2003	American Board of Anatomic and Clinical Pathology
2001	Illinois Physician License

Experience & Service

Faculty Academic Appointments

Associate Professor, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019

Associate Professor, Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2019

Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2019

Assistant Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2014

Assistant Professor, Department of Pathology, Baylor College of Medicine, Houston, TX, 2006 - 2008

Assistant Professor, Department of Dermatopathology, Edward Hines, Jr VA Hospital, Hines, IL, 2005 - 2006

Assistant Professor, Department of Pathology, Loyola University Medical Center, Maywood, IL, 2004 - 2006

Administrative Appointments/Responsibilities

Director of Translational Molecular Pathology Dermatopathology Research Laboratory, Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present

Medical Director, Department of Pathology, Tissue Qualification Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - Present

Medical Director, Department of Pathology, Histology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016 - Present

Assistant Director of Dermatopathology Fellowship, Department of Pathology, Baylor College of Medicine, Houston, TX, 2006 - 2008

Other Professional Positions

Dermatology Residence Education Committee, Loyola University Medical Center, Maywood, IL, 2005 - 2006

Representative, House Staff Governance Committee, Loyola University Medical Center, Maywood, IL, 1999 - 2000

Member, Blood Utilization Committee, Loyola University Medical Center, Maywood, IL, 1999 - 2000

Extramural Institutional Committee Activities

Member, Cancer Network Clinical Consultant, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, 2019 - Present

Biomarkers and Pathology Section, Leader, Immune-Oncology Working Group, The University of Texas MD Anderson Cancer Center, 2018 - Present

Member, Executive Operations Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present

Member, Frozen Section Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present

Member, MelCo Tissue Oversight Committee, The University of Texas MD Anderson Cancer Center, 2015 - Present

Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2013 - 2014

Member, Melanoma Moon Shot: Biospecimen collection, The University of Texas MD Anderson Cancer Center, 2013 - 2015

Member, Clinical Research Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2011

Editorial Activities

Member of Editorial Review Board, Journal of Cutaneous Pathology, 2017 - Present

Member of Editorial Review Board, Journal of ImmunoTherapy of Cancer, 2017 - 2019

Associate Editor, Journal of ImmunoTherapy of Cancer, 2017 - 2019

Section Editor, Archives of Pathology and Laboratory Medicine, 2013 - Present

Member of Editorial Review Board, Dermatology Research and Practice, 2009 - 2016

Honors & Awards

2025 - Present	American Society of Dermatopathology Mentorship Award, American Society of Dermatopathology
2008	Dermatology Foundation Research Award, Dermatology Foundation
2001	Research Scholars Award, College of American Pathologists Foundation
1997	Stein Pathology Scholarship

Professional Memberships

Society for Immunotherapy of Cancer

2017 - 2019

Harris County Medical Society

2013 - Present

Texas Medical Association

2013 - Present

American Society for Clinical Pathology

2012 - 2022

United States and Canadian Academy of Pathology

2006 - Present

Society of Investigative Dermatology

2006 - 2010

American Academy of Dermatology

2006 - 2010

College of American Pathologists

2005 - Present

International Society of Dermatopathology

2005 - 2012

American Society of Dermatopathology

2004 - Present

Selected Presentations & Talks

Local Presentations

2025. The Nuts and Bolts in Surgical Pathology. Invited. Houston, Texas, US.
2025. Adverse Skin Reactions to Novel Cancer Therapies. Invited. Houston, Texas, US.
2021. Multiplex Immunofluorescence Analysis of Bullous Pemphigoid Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy: Implications of CD8+ Regulatory T Cells, IOTOX Research Retreat. Conference. Houston, TX, US.
2020. Cutaneous Toxicities to Precision Cancer Therapy. Conference. Cutaneous Toxicities to Precision Cancer Therapy. Houston, TX, US.
2020. Cutaneous Toxicities in the Era of Oncodermatopathology. Conference. Cutaneous Toxicities in the Era of Oncodermatopathology. Houston, TX, US.
2019. "Pathology of Cutaneous Toxicities from Nibs and Mabs". Conference. "Pathology of Cutaneous Toxicities from Nibs and Mabs". Houston, TX, US.
2019. "Practical histopathologic considerations for orbit and ocular cancers". Conference. "Practical histopathologic considerations for orbit and ocular cancers". Houston, TX, US.
2018. Pathology of Immune-Oncology Toxicities of the Skin. Conference. Pathology of Immune-Oncology Toxicities of the Skin. Houston, TX, US.
2018. Dermatologic Reactions to Nibs and Mabs: Inflammatory, neoplastic, immunobullous, and much more. Conference. Dermatologic Reactions to Nibs and Mabs: Inflammatory, neoplastic, immunobullous, and much more. Houston, TX, US.
2018. Pathology Perspectives of Immune-Oncology Toxicities. Conference. Pathology Perspectives of Immune-Oncology Toxicities. Houston, TX, US.
2017. Inflammatory Dermatoses in Cancer Patients. Conference. Inflammatory Dermatoses in Cancer Patients. Houston, TX, US.
2016. Gross Examination and Tissue Processing of Skin Specimens. Conference. Gross Examination and Tissue Processing of Skin Specimens. Houston, TX, US.
2016. Pathology & Molecular Diagnostics in Melanoma. Conference. Pathology & Molecular Diagnostics in Melanoma. Houston, TX, US.
2014. Examination of Melanocytic and non-melanocytic lesions in cancer center patients. Conference. Examination of Melanocytic and non-melanocytic lesions in cancer center patients. Houston, TX, US.
2014. Melanoma: Understanding pathology perspectives and clinical applications. Conference. Melanoma: Understanding pathology perspectives and clinical applications. Houston, TX, US.
2013. Melanoma Medical Oncology: Diagnosis of Melanoma. Conference. Melanoma Medical Oncology: Diagnosis of Melanoma. Houston, TX, US.
2012. Syringocystadenocarcinoma papilliferum. Conference. Syringocystadenocarcinoma papilliferum. Houston, TX, US.
2011. Melanoma and Desmoplastic Melanocytic Lesions. Conference. Houston, TX, US.
2010. The function of p57 in melanoma and nevi. Conference. The function of p57 in melanoma and nevi. Houston, TX, US.
2008. The Role of p57 and GSK-3B in Melanocytic Neoplasms. Conference. Houston, TX, US.
2007. Dermatopathology Series. Conference. Houston, Texas, US.
2005. Immunopathogenesis of Psoriasis. Conference. Houston, Texas, US.

Regional Presentations

2006. Non-melanocytic skin cancers. Conference. Non-melanocytic skin cancers. Maywood, IL, US.
2004. Prognostic indicators in malignant melanoma. Conference. Prognostic indicators in malignant melanoma. Maywood, IL, US.

National Presentations

2020. Course: Essentials of Oncodermatopathology Cutaneous Reactions to Novel Cancer Therapies and Beyond. Conference. Course: Essentials of Oncodermatopathology Cutaneous Reactions to Novel Cancer Therapies and Beyond, US.
2019. Dermatopathology of Immune-Oncology Toxicities: Pathways driving cutaneous immune-related adverse events from immune checkpoint inhibitors. Conference. Chicago, IL, US.
2018. Targeted and Checkpoint Inhibitor Therapy Associated Cutaneous Toxicities. Conference. Targeted and Checkpoint Inhibitor Therapy Associated Cutaneous Toxicities. Chicago, IL, US.
2017. Gene expression profiling of dermatologic toxicities from immune checkpoint therapy. Conference. Society for Immunotherapy of Cancer. National Harbor, MD, US.
2016. Clinical and Histologic Patterns of Dermatologic Toxicity from Immune Checkpoint Blockade Therapy. Conference. The 2nd Inflammatory Skin Disease Summit. New York, NY, US.
2016. Melanoma staging and mutation biomarkers: Review, Update, and Pitfalls. Conference. Houston, TX, US.
2014. Developing Trends in Melanoma: Ancillary Techniques for Diagnosis and New Targeted Therapies and their Cutaneous Side Effects. Conference. American Society for Clinical Pathology. Tampa, FL, US.
2014. Immunohistochemistry for Histone H3K79me3T80ph Is Superior to PHH3 in the Detection of Mitotic Chromatin and G2 Positive Nuclei in Merkel Cell Carcinoma. Conference. Immunohistochemistry for Histone H3K79me3T80ph Is Superior to PHH3 in the Detection of Mitotic Chromatin and G2 Positive Nuclei in Merkel Cell Carcinoma. San Diego, CA, US.
2014. Shared Clonality in Distinctive Lesions of Lymphomatoid Papulosis and Mycosis Fungoides Occurring in the Same Patients Suggests a Common Origin. Conference. Shared Clonality in Distinctive Lesions of Lymphomatoid Papulosis and Mycosis Fungoides Occurring in the Same Patients Suggests a Common Origin. San Diego, CA, US.
2014. Tumor size correlates with survival in melanomas associated with conventional or cellular blue nevi or displaying blue nevus-like features (so called malignant blue nevus). Conference. Tumor size correlates with survival in melanomas associated with conventional or cellular blue nevi or displaying blue nevus-like features (so called malignant blue nevus). San Diego, CA, US.
2014. p40 improves diagnostic specificity between Atypical Fibroxanthoma and poorly differentiated Squamous Cell Carcinoma compared to p63. Conference. p40 improves diagnostic specificity between Atypical Fibroxanthoma and poorly differentiated Squamous Cell Carcinoma compared to p63. San Diego, CA, US.
2014. Melanoma with synchronous SMARCB1 and BRAF or TP53 mutations: a histologic, immunohistochemical and molecular analysis. Conference. Melanoma with synchronous SMARCB1 and BRAF or TP53 mutations: a histologic, immunohistochemical and molecular analysis. San Diego, CA, US.
2014. Primary Acral Lentiginous Melanoma in Patients with Non-Caucasian Ethnicities from East Asia and Latin America Demonstrates Frequent Heterogenous Immunodetection of BRAFV600E and Preserved PTEN Protein Expression. Conference. Primary Acral Lentiginous Melanoma in Patients with Non-Caucasian Ethnicities from East Asia and Latin America Demonstrates Frequent Heterogenous Immunodetection of BRAFV600E and Preserved PTEN Protein Expression. San Diego, CA, US.
2013. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) shows frequent association with acute myeloid leukemia (AML): a single institution experience. Conference. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) shows frequent association with acute myeloid leukemia (AML): a single institution experience. Washington, DE, US.
2013. Current uses of new and established immunohistochemical markers. Conference. The American Society of Dermatopathology. Washington, DC, US.
2013. Developing Trends in Melanoma: Application of Ancillary Techniques for Diagnosis and Prognosis, Use of New Targeted Therapies and Their Associated Cutaneous Side Effects. Conference. American Society for Clinical Pathology. Chicago, IL, US.
2013. Self-Assessment Course. Conference. American Academy of Dermatology & International Society of Dermatology. Miami, FL, US.
2013. Molecular Aspects of Cutaneous Melanoma. Conference. Troy, MI, US.
2013. Pigmented extramammary Paget disease of the thigh mimicking a melanocytic nevus: a diagnostic pitfall. Conference. Pigmented extramammary Paget disease of the thigh mimicking a melanocytic nevus: a diagnostic pitfall. Washington, DE, US.
2013. Malignant neurocristic hamartoma with EWSR1 gene rearrangement detected by fluorescent in situ hybridization (FISH). Conference. Malignant neurocristic hamartoma with EWSR1 gene rearrangement detected by fluorescent in situ hybridization (FISH). Washington, DC, US.
2012. Final Tumor Stage and Sentinel Lymph Node Status on Initial Biopsies in Thin Cutaneous Melanomas Transected at the Base. Conference. The American Society of Dermatopathology. Chicago, IL, US.
2010. Tissue biomarkers in evaluating melanocytic neoplasms Current Trends in the Genetics of Melanoma and Clinical Implications. Conference. Tucson, AZ, US.
2010. Clinical implications of 2009 AJCC melanoma staging and classification system Current Trends in the Genetics of Melanoma and Clinical Implications. Conference. Tucson, AZ, US.
2009. Review of Soft Tissue Neoplasm. Conference. Chicago, IL, US.
2009. An Update of Soft Tissue Tumors of the Skin. Conference. Maywood, IL, US.
2004. Krox-20 expression is increased in psoriasis. Conference. The American Society of Dermatopathology. Boston, MA, US.
2002. Innate immune-related reactions intrinsic to symptomless psoriatic skin. Conference. Society for Investigative Dermatology. Los Angeles, CA, US.
2001. Dermatofibrosarcoma protuberans-fibrosarcoma. Conference. Chicago, IL, US.
2001. The Effects of Current WHO/ISUP Bladder Neoplasia Classification System on Urine Cytology Results. Conference. United States and Canadian Academy of Pathology (USCAP). Atlanta, GA, US.
2000. Human Keratinocytes Express Functional alpha-MSH (MC1-R) receptors. Conference. United States and Canadian Academy of Pathology (USCAP). New Orleans, LA, US.
2000. Mesenchymal Chondrosarcoma. Conference. Chicago, IL, US.
1998. Necrotizing Enterocolitis. Conference. American Medical Association Sponsored Clinical Vignettes. Maywood, IL, US.

International Presentations

2024. Adverse Skin Reactions in the Eras of Novel Targeted Cancer Therapies. Invited. Bangkok, TH.
2023. Reactions to targeted therapies. Invited. The 25th World Congress of Dermatology. Singapore, SG.
2023. Pathological considerations of conjunctival neoplasm. Invited. The Second Symposium in Anatomic Pathology: Advancements in Cancer Research. Bari, IT.
2023. Neoplastic and inflammatory adverse skin reactions in the era of onco-dermatopathology. Invited. The Second Symposium in Anatomic Pathology: Advancements in Cancer Research. Bari, IT.
2023. Challenging cases in dermatopathology. Invited. The Second Symposium in Anatomic Pathology: Advancements in Cancer Research. Bari, IT.
2023. Issues with post-neoadjuvant therapy specimens. Invited. The Second Symposium in Anatomic Pathology: Advancements in Cancer Research. Bari, IT.
2022. Unraveling the Immune Mechanisms of Cutaneous Adverse Reactions from Checkpoint Inhibitors. Invited. Bangkok, TH.
2019. Pathology of cutaneous adverse reactions from immune checkpoint inhibitor therapy. Conference. Pathology of cutaneous adverse reactions from immune checkpoint inhibitor therapy. Guatemala City, GT.
2019. Oncodermatopathology: The intersection of medical oncology and dermatopathology. Conference. Oncodermatopathology: The intersection of medical oncology and dermatopathology. London, GB.
2017. Inflammatory and neoplastic dermatopathology. Unknown slide session. Invited. Bangkok, TH.
2017. Dermatologic Toxicities from anti-PD-1 Immune Checkpoint Therapy: Update on the Dermatopathology Findings. Invited. Bangkok, TH.
2014. Biomarkers in Melanoma: An Update and Clinical Applications. Invited. Bangkok, TH.
2012. Implications of the 2009 AJCC Melanoma Staging and Classification System for Thin Melanomas. Conference. United States and Canadian Academy of Pathology (USCAP). Vancouver, CA.
2012. The Utility of ATF3 in Cutaneous Epithelial Neoplasms. Conference. United States and Canadian Academy of Pathology (USCAP). Vancouver, CA.
2012. Dermatopathologic Features of Cutaneous Toxicities Related to Targeted Cancer Therapy. Invited. Bangkok, TH.
2012. What is New in Dermatopathology? From Neoplastic to Inflammatory Conditions/New Adjuvant Therapies: Cutaneous Effects. Conference. 101st Annual Meeting of the United States and Canadian Academy of Pathology. Vancouver, CA.
2012. Clinical Correlates of Specific BRAF and NRAS Mutations in Melanoma. Conference. United States and Canadian Academy of Pathology (USCAP). Vancouver, CA.
2010. Update on tissue biomarkers in melanoma. Invited. Bangkok, TH.

Less

Grant & Contract Support

Date:	2019 - 2021
Title:	Pathogenesis of immune-oncology skin toxicities
Funding Source:	The University of MD Anderson Cancer Center
Role:	PI

Date:	2017 - 2018
Title:	SPORE in Melanoma
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2017 - 2018
Title:	Characterization of the immune infiltrates associated with dermatologic toxicity arising during immune checkpoint inhibitor therapy for cancer
Funding Source:	The University of MD Anderson Cancer Center
Role:	Principal Investigator-MDACC

Date:	2013 - 2015
Title:	Melanoma Moon Shot Program
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Team Member

Date:	2008 - 2009
Title:	The role of p57KIP2 signaling in melanocytic nevi and cutaneous melanoma
Funding Source:	Dermatology Foundation
Role:	PI

Date:	2001 - 2002
Title:	Identifying the Genetic Determinant of Psoriasis
Funding Source:	College of American Pathologists Foundation
Role:	Trainee

Selected Publications

Peer-Reviewed Articles

Likki, S, Lee, KP, Muhaj, FF, Wang, W, Lin, P, Cho, WC, Ivan, D, Torres Cabala, CA, Fayad, LE, Curry, JL. Diffuse cutaneous ALK-immunoreactive histiocytosis with MEF2C::FLT3 fusion. JAAD Case Reports 65:233-236, 2025. e-Pub 2025. PMID: 41211348.
Pacha, O, Patel, A, Curry, JL, Haymaker, CL, Ozirmak Lermi, N, Duose, D, Chen, K, Hajjar, J, Naing, A. Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors. Journal for immunotherapy of cancer 13(8), 2025. e-Pub 2025. PMID: 40780859.
Chien, KS, Curry, JL, Pemmaraju, N, Jain, N. Leukemia Cutis in the Setting of Indolent Chronic Lymphocytic Leukemia. American journal of hematology 100(7):1240-1241, 2025. e-Pub 2025. PMID: 40062658.
Do, J, Wang, Y, Aung, PP, Nagarajan, P, Ning, J, Curry, JL, Ivan, D, Lenskaya, V, Torres Cabala, CA, Prieto, V, Cho, WC. INSM1. Human Pathology 160, 2025. e-Pub 2025. PMID: 40505699.
He, LJ, Wang, Y, Curry, JL, Ning, J, Aung, PP, Nagarajan, P, Prieto, V, Torres Cabala, CA, Cho, WC. TROP2 is highly expressed in cutaneous squamous cell carcinomas and a subset of adnexal carcinomas. Human Pathology 160, 2025. e-Pub 2025. PMID: 40523445.
Moussa, MJ, Wilson, NR, Ghosh, A, Bhattacharjee, M, Curry, JL, Cho, WC, Patel, A, Habra, MA, Thosani, S, Campbell, M, Siefker-Radtke, AO, Alhalabi, O, Kikani, NJ. Systemic Toxicity With Hyperglycemia or Diabetic Ketoacidosis After Enfortumab Vedotin. Annals of Internal Medicine Clinical Cases 4(5), 2025. e-Pub 2025.
Gao, Y, Yang, RK, Curry, JL, Torres Cabala, CA, Cho, WC. Melanoma with RNF11::BRAF Fusion: A Novel Fusion Previously Undescribed in Melanoma. American Journal of Dermatopathology 47(5):391-394, 2025. e-Pub 2025. PMID: 40036483.
Bayraktar, EC, Aung, PP, Gill, P, Shen, G, Vasudevaraja, V, Lai, Z, Chiriboga, L, Ivan, D, Nagarajan, P, Curry, JL, Torres Cabala, CA, Prieto, V, Jour, G. Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes. Journal of cutaneous pathology 52(4):309-316, 2025. e-Pub 2025. PMID: 39757862.
Sun X, Axelrod ML, Gonzalez-Ericsson PI, Sanchez V, Wang Y, Curry JL, Phillips EJ, Xu Y, Johnson DB, Balko JM. Molecular analysis of immune checkpoint inhibitor associated erythema nodosum-like toxicity. Front Immunol 16:1542499, 2025. e-Pub 2025. PMID: 40181973.
Pineda-Reyes, J, Arudra, SC, Aung, PP, Nagarajan, P, Curry, JL, Tetzlaff, M, Prieto, V, Wang, W, Hwu, W, Torres Cabala, CA. Dual PD-L1/SOX10 Immunohistochemistry Combined with Digital Imaging Enhances Stratification Accuracy of Patients with Metastatic Melanoma. American Journal of Surgical Pathology 48(12):1551-1556, 2024. e-Pub 2024. PMID: 39373029.
Ledesma, D, Marques-Piubelli, ML, Li Ning Tapia, E, Hudgens, CW, Gu, J, Segura Lazcano, R, Casavilca, S, Castillo, M, Davies, MA, Hwu, WJ, Aung, PP, Giubellino, A, Curry, JL, Torres Cabala, CA. Apoptosis Pathway–Associated Proteins Are Frequently Expressed in Melanoma. American Journal of Dermatopathology 46(7):410-415, 2024. e-Pub 2024. PMID: 38718197.
Salah, HT, Yang, RK, Roy Chowdhuri, S, Ross, MI, Aung, PP, Rothrock, AT, Torres Cabala, CA, Curry, JL, Prieto, V, Nagarajan, P, Cho, WC. Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review. Journal of cutaneous pathology 51(6):407-414, 2024. e-Pub 2024. PMID: 38444194.
Seervai RNH, Taylor MM, Rahbar Z, Patel SP, Nelson KC, Prieto VG, Curry JL. Keratosis Pilaris-Like Reaction Associated With Chromatin Remodeling Complex Inhibition in Uveal Melanoma. JAMA Dermatol 160(6):682-685, 2024. e-Pub 2024. PMID: 38717752.
Cho, WC, Saade, R, Nagarajan, P, Aung, PP, Milton, D, Marques-Piubelli, ML, Hudgens, CW, Ledesma, D, Nelson, KC, Ivan, D, Zhang, M, Torres Cabala, CA, Campbell, M, Alhalabi, O, Prieto, V, Wistuba, II, Esmaeli, B, Curry, JL. Nectin-4 expression in a subset of cutaneous adnexal carcinomas. Journal of cutaneous pathology 51(5):360-367, 2024. e-Pub 2024. PMID: 38200650.
Musicante M, Harrell JM, Kubicki S, Curry JL, Patel AB. When leukaemia masquerades: the hidden syphilis diagnosis. Lancet Oncol 25(5):e225, 2024. e-Pub 2024. PMID: 38697168.
Marques-Piubelli, ML, Navarrete, J, Ledesma, D, Hudgens, CW, Segura Lazcano, R, Alani, A, Huen, A, Duvic, M, Nagarajan, P, Aung, PP, Wistuba, II, Curry, JL, Miranda, RN, Torres Cabala, CA. Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells 13(5), 2024. e-Pub 2024. PMID: 38474383.
Liu, YA, Aung, PP, Wang, Y, Ning, J, Nagarajan, P, Curry, JL, Torres Cabala, CA, Ivan, D, Prieto, V, Ding, Q, Cho, WC. TRPS1 expression in non-melanocytic cutaneous neoplasms. Journal of Pathology and Translational Medicine 58(2):72-80, 2024. e-Pub 2024. PMID: 38389280.
Liu YA, Collins K, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC. TRPS1 expression in primary and secondary extramammary Paget diseases: An immunohistochemical analysis of 93 cases. Hum Pathol 143:5-9, 2024. e-Pub 2024. PMID: 38000676.
Ronen S, McAfee JL, Curry JL, Nagarajan P, Aung PP, Ivan D, Prieto VG, Tetzlaff MT, Torres-Cabala C. Phenotypic switch in mycosis fungoides: A tertiary cancer center experience. Hum Pathol 142:27-33, 2023. e-Pub 2023. PMID: 37977511.
Cho WC, Li W, Gu J, Wang WL, Ning J, Sfamenos S, Gill P, Nagarajan P, Curry JL, Lazar AJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma. J Cutan Pathol 50(9):845-851, 2023. e-Pub 2023. PMID: 37400233.
Vanderbeck K, Rothrock AT, Cho WC, Nagarajan P, Aung PP, Hudgens C, Bassett RL, Ivan D, Prieto VG, Curry JL, Torres-Cabala CA. PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls. Am J Dermatopathol 45(8):549-556, 2023. e-Pub 2023. PMID: 37462205.
Niu N, Heberton MM, Tang Z, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review. J Cutan Pathol 50(8):711-716, 2023. e-Pub 2023. PMID: 36944579.
Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma. Arch Pathol Lab Med 147(7):758-766, 2023. e-Pub 2023. PMID: 36745184.
Marques-Piubelli ML, Seervai RNH, Mudaliar KM, Ma W, Milton DR, Wang J, Muhlbauer A, Parra ER, Solis LM, Nagarajan P, Speiser J, Hudgens C, Cho WC, Aung PP, Patel A, Pacha O, Nelson KC, Tetzlaff MT, Amaria RN, Torres-Cabala CA, Prieto VG, Wistuba II, Curry JL. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T(H) 1 T-cells. J Cutan Pathol 50(7):661-673, 2023. e-Pub 2023. PMID: 37150813.
Vanderbeck K, Cho WC, Aung PP, Ivan D, Rothrock AT, Torres-Cabala CA, Prieto VG, Curry JL, Nagarajan P. Ductal differentiation: A rare phenomenon in Merkel cell carcinoma. J Cutan Pathol 50(6):511-519, 2023. e-Pub 2023. PMID: 36454019.
Cho WC, Ding Q, Wang WL, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Albarracin CT, Sahin A, Prieto VG, Aung PP. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics. J Cutan Pathol 50(5):434-440, 2023. e-Pub 2023. PMID: 36808637.
Rothrock AT, Hameed N, Cho WC, Nagarajan P, Ivan D, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes. J Cutan Pathol 50(3):223-229, 2023. e-Pub 2023. PMID: 36377266.
Bartley B, Cho WC, Rady PL, Dai J, Curry JL, Milbourne A, Tyring SK, Torres-Cabala CA. Condyloma and coincidental epidermodysplasia verruciformis acanthoma positive for human papillomavirus-14 and -21. J Cutan Pathol 50(1):47-50, 2023. e-Pub 2023. PMID: 36039682.
Martel J, Cho WC, Runge JS, Patel AB, Tayar J, Woodman K, Hume CB, Curry J, Heberton M. Durvalumab-associated generalized morphea with overlapping vitiligo. JAAD Case Rep 30:83-86, 2022. e-Pub 2022. PMID: 36407485.
Qian J, Kubicki SL, Curry JL, Jahan-Tigh R, Benjamin R, Heberton M, Nelson KC. Pembrolizumab-induced rash in a patient with angiosarcoma. JAAD Case Rep 29:21-24, 2022. e-Pub 2022. PMID: 36186410.
Rothrock AT, Torres-Cabala CA, Milton DR, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Ivan D, Prieto VG, Aung PP. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions. J Cutan Pathol 49(10):859-867, 2022. e-Pub 2022. PMID: 35794643.
Rothrock AT, Truong LD, Shehabeldin A, Wong MKK, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Amyloid deposition with a granulomatous reaction in a resection specimen: A clue for a preexisting Merkel cell carcinoma. J Cutan Pathol 49(9):787-790, 2022. e-Pub 2022. PMID: 35734844.
Kim K, Bazinet A, Loghavi S, Konopleva M, Bhalla K, Daver N, Khoury JD, Kadia T, Wilson NR, Curry JL, Heberton M, Miller D, Pierce S, Borthakur G, Pemmaraju N. Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine. Leuk Res 119:106884, 2022. e-Pub 2022. PMID: 35691130.
Farah M, Milton, Gross ND, Nagarajan P, Gu J, Curry JL, Ivan D, Torres-Cabala CA, Myers JN, Prieto VG, Aung PP. Histopathologic Features Predictive of Metastasis and Survival in 230 Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck and Non-Head and Neck Locations: A Single-Center Retrospective Study. J Eur Acad Dermatol Venereol 36(8):1246-1255, 2022. e-Pub 2022. PMID: 35426183.
Fisher KE, Ferguson LS, Coffey AM, Merritt BY, Curry JL, Marcogliese AN, Major AM, Kamdar KY, Lopez-Terrada DH, Curry CV. Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance. Haematologica 107(8):1880-1890, 2022. e-Pub 2022. PMID: 35081690.
Bartley BR, Huen A, Rady PL, Tyring SK, Nagarajan P, Aung PP, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG, Cho WC. Eosinophilic Homogeneous Intracytoplasmic Inclusion Bodies: Unique Viral Cytopathic Changes to be Associated with Epidermodysplasia Verruciformis and Human Papillomavirus Type 49. J Cutan Pathol 49(7):658-662, 2022. e-Pub 2022. PMID: 35262953.
Hailemichael, Y, Johnson, DH, Hassan, NA, Foo, WC, Bentebibel, SE, Daher, M, Haymaker, CL, Wani, K, Saberian, C, Ogata, D, Kim, ST, Nurieva, R, Lazar, A, Abu-Sbeih, H, Fa'Ak, F, Mathew, A, Wang, Y, Falohun, A, Trinh, VA, Zobniw, C, Spillson, C, Burks, JK, Awiwi, M, Elsayes, KM, Solis Soto, LM, Melendez, B, Davies, MA, Wargo, J, Curry, JL, Yee, C, Lizee, GA, Singh, S, Sharma, P, Allison, JP, Hwu, P, Ekmekcioglu, S, Diab, A. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer cell 40(5):509-523.e6, 2022. e-Pub 2022. PMID: 35537412.
Seervai RNH, Heberton M, Cho WC, Gill P, Murphy MB, Aung PP, Nagarajan P, Torres-Cabala CA, Patel AB, Ruiz-Bañobre J, Om A, Yamamoto T, Nikolaou V, Curry JL. Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma. J Cutan Pathol 49(5):472-481, 2022. e-Pub 2022. PMID: 34888886.
Bloomquist MS, Curry JL, Krishnan B, Rivero G, Curry CV, Diwan AH. Ibrutinib skin toxicities: Report of two cases. J Cutan Pathol 49(4):363-368, 2022. e-Pub 2022. PMID: 34726785.
Cho WC, Gill P, Nagarajan P, Aung PP, Torres-Cabala CA, Curry JL, Ivan D, Lester L, Prieto VG. Cutaneous Lymphoid Hyperplasia With T-Cell Clonality and Monotypic Plasma Cells Secondary to a Tick Bite: A Hidden Critter and the Power of Deeper Levels. Am J Dermatopathol 44(3):226-229, 2022. e-Pub 2022. PMID: 35050559.
Ronen S, Al-Rohil RN, Keiser E, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Middleton LP, Torres-Cabala CA, Gershenwald JE, Aung PP, Prieto VG. Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management. Arch Pathol Lab Med 145(12):1505-1522, 2021. e-Pub 2021. PMID: 33577643.
Nguyen CN, Iyer SP, Miranda RN, Torres-Cabala CA, Curry JL, Fang P, Thomas VD, Huen AO. Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse. JAAD Case Rep 17:34-37, 2021. e-Pub 2021. PMID: 34692965.
Cho WC, Gill P, Aung PP, Gu J, Nagarajan P, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. The utility of digital pathology in improving the diagnostic skills of pathology trainees in commonly encountered pigmented cutaneous lesions during the COVID-19 pandemic: A single academic institution experience. Ann Diagn Pathol 54:151807, 2021. e-Pub 2021. PMID: 34418768.
Wu C, Peng S, Pilie PG, Geng C, Park S, Manyam GC, Lu Y, Yang G, Tang Z, Kondraganti S, Wang D, Hudgens CW, Ledesma DA, Marques-Piubelli ML, Torres Cabala CA, Curry JL, Troncoso P, Corn PG, Broom BM, Thompson TC. PARP and CDK4/6 inhibitor combination therapy induces apoptosis and suppresses neuroendocrine differentiation in prostate cancer. Mol Cancer Ther 20(9):1680-1691, 2021. e-Pub 2021. PMID: 34158347.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Nagarajan P, Curry JL, Ciurea AM, Rubin AI, Hwu WJ, Prieto VG, Aung PP. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma. Arch Pathol Lab Med 145(8):943-952, 2021. e-Pub 2021. PMID: 33290520.
Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?. Virchows Arch 479(2):377-383, 2021. e-Pub 2021. PMID: 33604757.
Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma. Arch Pathol Lab Med 145(7):842-850, 2021. e-Pub 2021. PMID: 33053175.
Wiggins CJ, Morris VK, Klimas NK, Nagarajan P, Curry JL, Richards KN. Bullous pemphigoid secondary to bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1. JAAD Case Rep 13:23-25, 2021. e-Pub 2021. PMID: 34136620.
Sweeney KJ, Tetzlaff MT, Vega F, Gillenwater A, Zuo Z, Gross N, Nagarajan P, Wargo J, Nelson K, Prieto VG, Torres-Cabala CA, Curry JL. Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response. J Cutan Pathol 48(5):674-679, 2021. e-Pub 2021. PMID: 33399228.
Ronen S, Keiser E, Collins KM, Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Hymes S, Medeiros LJ, Torres-Cabala CA. Langerhans cell sarcoma involving skin and showing epidermotropism: a comprehensive review. J Cutan Pathol 48(4):547-557, 2021. e-Pub 2021. PMID: 32644218.
Kwon D, Ronen S, Giubellino A, Keiser E, Aung PP, Nagarajan P, Tetzlaff MT, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Cutaneous Adnexal Carcinosarcoma: Immunohistochemical and Molecular Evidence of Epithelial Mesenchymal Transition. J Cutan Pathol 48(4):526-534, 2021. e-Pub 2021. PMID: 32564423.
McNally MA, Vangipuram R, Campbell MT, Nagarajan P, Patel AB, Curry JL, Heberton M. Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma. JAAD Case Rep 10:82-84, 2021. e-Pub 2021. PMID: 33778141.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma. Mod Pathol 34(3):572-583, 2021. e-Pub 2021. PMID: 32759976.
Miller, A, Siller, A, Rodriguez, R, Gill, P, Curry, JL, Tyring, SK. A pearly nodule on an indurated plaque. Dermatology online journal 27(12), 2021. e-Pub 2021. PMID: 35499445.
Karri P, Freemyer B, Aboul-Fettouh N, Patel AB, Curry JL, Rogge M. Plasma cell myeloma with immature plasma cells in the skin arising within the areas of chronic stasis dermatitis. JAAD Case Rep 7:26-29, 2021. e-Pub 2021. PMID: 33318997.
Viscuse PV, Marques-Piubelli ML, Heberton MM, Parra ER, Shah AY, Siefker-Radtke A, Gao J, Goswami S, Ivan D, Curry JL, Campbell MT. Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction. Front Oncol 11:621591, 2021. e-Pub 2021. PMID: 33747934.
Farah M, Reuben A, Spassova I, Yang RK, Kubat L, Nagarajan P, Ning J, Li W, Aung PP, Curry JL, Torres-Cabala CA, Hudgens CW, Ugurel S, Schadendorf D, Gumbs C, Little LD, Futreal A, Wistuba II, Prieto VG, Wang L, Wong MK, Wargo JA, Becker JC, Tetzlaff MT. T CELL REPERTOIRE IN COMBINATION WITH T CELL DENSITY PREDICTS CLINICAL OUTCOMES IN PATIENTS WITH MERKEL CELL CARCINOMA. J Invest Dermatol 140(11):2146-2156.e4, 2020. e-Pub 2020. PMID: 32304704.
Eriksson H, Hansson J, Krynitz B, Masucci G, Girnita A, Lapins J, Huen AO, Tawbi HA, Davies MA, Tetzlaff MT, Curry JL. Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma. Acta Derm Venereol 100(18):adv00334, 2020. e-Pub 2020. PMID: 32985676.
Marques-Piubelli ML, Tetzlaff MT, Nagarajan P, Duke TC, Glitza Oliva IC, Ledesma DA, Aung PP, Torres-Cabala CA, Wistuba II, Prieto VG, Nelson KC, Curry JL. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma. J Cutan Pathol 47(10):954-959, 2020. e-Pub 2020. PMID: 32394425.
Ramani NS, Aung PP, Gu J, Sfamenos S, Sdringola-Maranga C, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Diab A, Prieto VG, Hwu WJ, Torres-Cabala CA. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis. Mod Pathol 33(10):2067-2074, 2020. e-Pub 2020. PMID: 32404956.
Farah M, Nelson KC, Tetzlaff MT, Nagarajan P, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report. J Cutan Pathol 47(5):490-493, 2020. e-Pub 2020. PMID: 31930527.
Yildiz P, Aung PP, Milton DR, Hruska C, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala C, Prieto VG. Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data?. Am J Dermatopathol 42(5):337-342, 2020. e-Pub 2020. PMID: 31464719.
Chen PL, Neishaboori N, Tetzlaff MT, Chen WS, Aung PP, Curry JL, Nagarajan P, Ivan D, Hwu WJ, Prieto VG, Torres-Cabala CA. BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma. Am J Dermatopathol 42(5):313-321, 2020. e-Pub 2020. PMID: 32310893.
Bush, AE, Garcia, A, Li, JY, Curry, JL, Chon, S. CD30+ lymphomatoid skin toxicity secondary to ipilimumab. JAAD Case Reports 6(4):251-253, 2020. e-Pub 2020. PMID: 32211493.
Robinson S, Saleh J, Curry JL, Mudaliar K. Pembrolizumab-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Patient With Metastatic Cervical Squamous Cell Carcinoma: A Case Report. Am J Dermatopathol 42(4):292-296, 2020. e-Pub 2020. PMID: 31567395.
Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol 33(3):496-513, 2020. e-Pub 2020. PMID: 31383963.
Mejbel HA, Nelson KC, Pradhan D, Ivan D, Zaleski M, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Cutaneous Neoplasms Composed of Melanoma and Carcinoma: A Rare but Important Diagnostic Pitfall and Review of the Literature. J Cutan Pathol 47(1):36-46, 2020. e-Pub 2020. PMID: 31361351.
Namikawa K, Aung PP, Milton DR, Tetzlaff MT, Torres-Cabala CA, Curry JL, Nagarajan P, Ivan D, Ross M, Gershenwald JE, Prieto VG. Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma. Clin Cancer Res 25(24):7585-7593, 2019. e-Pub 2019. PMID: 31570567.
Esmaeli B, Rubin ML, Xu S, Goepfert RP, Curry JL, Prieto VG, Ning J, Tetzlaff MT. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications For Future AJCC Classifications. Am J Surg Pathol 43(12):1701-1710, 2019. e-Pub 2019. PMID: 31425167.
Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. Cancers (Basel) 11(12), 2019. e-Pub 2019. PMID: 31888295.
Tetzlaff MT, Tang S, Duke T, Grabell DA, Cabanillas ME, Zuo Z, Yao JC, Nagarajan P, Aung PP, Torres-Cabala CA, Duvic M, Prieto VG, Huen A, Curry JL. Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features. J Cutan Pathol 46(11):872-877, 2019. e-Pub 2019. PMID: 31254410.
Mejbel HA, Arudra SKC, Pradhan D, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Duose DY, Luthra R, Prieto VG, Ballester LY, Aung PP. Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity. Cancers (Basel) 11(11), 2019. e-Pub 2019. PMID: 31684113.
Abu-Sbeih H, Tang T, Ali FS, Luo W, Neelapu SS, Westin JR, Okhuysen PC, Foo WC, Curry JL, Richards DM, Ge PS, Wang Y. Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy. Am J Clin Oncol 42(10):789-796, 2019. e-Pub 2019. PMID: 31478934.
Johnson DH, Patel AB, Uemura MI, Trinh VA, Jackson N, Zobniw CM, Tetzlaff MT, Hwu P, Curry JL, Diab A. IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy. Cancer Immunol Res 7(6):860-865, 2019. e-Pub 2019. PMID: 30996018.
Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres-Cabala CA, Efstathiou E, Hoang AG, Wong MK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba I, Tetzlaff MT. B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density. Clin Cancer Res 25(11):3455-3467, 2019. e-Pub 2019. PMID: 30808776.
Mauzo SH, Tetzlaff MT, Milton DR, Siroy AE, Nagarajan P, Torres-Cabala CA, Ivan D, Curry JL, Hudgens CW, Wargo JA, Sahin AA, Pettaway CA, Prieto VG, Aung PP. Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. Cancers (Basel) 11(6), 2019. e-Pub 2019. PMID: 31146499.
Trinidad CM, Torres-Cabala CA, Curry JL, Prieto VG, Aung PP. Update on eighth edition American Joint Committee on Cancer classification for cutaneous melanoma and overview of potential pitfalls in histological examination of staging parameters. J Clin Pathol 72(4):265-270, 2019. e-Pub 2019. PMID: 30275100.
Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series. Am J Dermatopathol 41(3):167-179, 2019. e-Pub 2019. PMID: 30801340.
Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl T, Peng B, Bell D, Routbort MJ, Hudgens CW, Ivan D, Kim T, Chen K, Eterovic AK, Shaw KRM, Prieto VG, Yemelyanova A, Esmaeli B. Distinct biological types of ocular adnexal sebaceous carcinoma: HPV-driven and virus-negative tumors arise through non-overlapping molecular-genetic alterations. Clin Cancer Res 25(4):1280-1290, 2019. e-Pub 2019. PMID: 30420449.
Farah M, Nagarajan P, Curry JL, Tang Z, Kim TB, Aung PP, Torres-Cabala CA, Eterovic AK, Wargo JA, Prieto VG, Tetzlaff MT. Spitzoid melanoma with histopathologic features of ALK gene rearrangement exhibiting ALK copy number gain: A novel mechanism of ALK activation in spitzoid neoplasia. Br J Dermatol 180(2):404-408, 2019. e-Pub 2019. PMID: 29897634.
Konopinski JC, Danialan R, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Prieto VG, Aung PP. Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma. Hum Pathol 84:270-274, 2019. e-Pub 2019. PMID: 30359637.
Fedda F, Migden MR, Curry JL, Torres-Cabala CA, Tetzlaff MT, Aung PP, Prieto VG, Ivan D, Myers JN, Nagarajan P. Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spread. J Cutan Pathol 46(2):152-158, 2019. e-Pub 2019. PMID: 30414196.
Mauzo SH, Tetzlaff MT, Nelson K, Amaria R, Patel S, Aung PP, Nagarajan P, Torres-Cabala CA, Diab A, Prieto VG, Curry JL. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. Int J Dermatol 58(9):1045-1052, 2019. e-Pub 2019. PMID: 29152725.
Curry JL, Reuben A, Szczepaniak-Sloane R, Ning J, Milton DR, Lee CH, Hudgens C, George S, Torres-Cabala C, Johnson D, Subramanya S, Wargo JA, Mudaliar K, Wistuba II, Prieto VG, Diab A, Tetzlaff MT. Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response. J Cutan Pathol 46(9):627-636, 2019. e-Pub 2019. PMID: 30883858.
Curry JL, Tetzlaff MT, Wang SA, Landon G, Alouch N, Patel SP, Nagarajan P, Gupta S, Aung PP, Devine CE, Khoury JD, Loghavi S, Prieto VG, DiNardo CD, Gershenwald JE. Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall. Am J Dermatopathol 40(11):831-835, 2018. e-Pub 2018. PMID: 29863571.
Chen WS, Tetzlaff MT, Diwan H, Jahan-Tigh R, Diab A, Nelson K, Glitza IC, Kaunitz GJ, Johnson D, Torres-Cabala C, Pacha O, Taube JM, Maloney K, Prieto VG, Curry JL. Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions. J Cutan Pathol 45(10):764-773, 2018. e-Pub 2018. PMID: 29943453.
Arudra K, Patel R, Tetzlaff MT, Hymes S, Subbiah V, Meric-Bernstam F, Torres-Cabala C, Aung PP, Nagarajan P, Diab A, Prieto VG, Nelson K, Curry JL. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. J Cutan Pathol 45(10):786-790, 2018. e-Pub 2018. PMID: 30021048.
Farah M, Nagarajan P, Torres-Cabala CA, Curry JL, Amaria RN, Wargo J, Tawbi H, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfall. J Cutan Pathol 45(7):545-549, 2018. e-Pub 2018. PMID: 29672900.
Al-Rohil RN, Milton DR, Nagarajan P, Curry JL, Feldmeyer L, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Intratumoral and Peritumoral Lymphovascular Invasion Detected by D2-40 Immunohistochemistry Correlates with Metastasis in Primary Cutaneous Merkel Cell Carcinoma. Hum Pathol 77:98-107, 2018. e-Pub 2018. PMID: 29601841.
Dolkar T, Trinidad CM, Nelson KC, Amaria RN, Nagarajan P, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Curry JL, Aung PP. Dermatologic Toxicity from Novel Therapy using Antimicrobial Peptide LL-37 in Melanoma: A Detailed Examination of the Clinicopathologic Features. J Cutan Pathol 45(7):539-544, 2018. e-Pub 2018. PMID: 29665030.
Trinidad C, Nelson KC, Glitza Oliva IC, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Ivan D, Hwu WJ, Prieto VG, Curry JL, Aung PP. Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern. J Cutan Pathol 45(7):504-507, 2018. e-Pub 2018. PMID: 29633300.
Mauzo SH, Milton DR, Prieto VG, Torres-Cabala CA, Wang WL, Chakravarti N, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Brown RE, Aung PP. Summary of expression of SPARC protein in cutaneous vascular neoplasms and mimickers. Ann Diagn Pathol 34:151-154, 2018. e-Pub 2018. PMID: 29660567.
Lewis DJ, Miranda RN, Oh CW, Hinojosa T, Medeiros LJ, Curry JL, Tetzlaff MT, Torres-Cabala CA, Nagarajan P, Ravandi-Kashani F, Duvic M. Pruritic arthropod bite-like papules in T-cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia. Clin Exp Dermatol 43(4):449-453, 2018. e-Pub 2018. PMID: 29423961.
Saenz-Ibarra B, Prieto VG, Torres-Cabala CA, Huen A, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Coccidioidomycosis Involving Lungs and Skin: A Mimicker of Metastatic Disease. Am J Dermatopathol 40(3):e41-e43, 2018. e-Pub 2018. PMID: 28857979.
Khan M, Siddiqi R, Curry JL, Naqvi K. Extensive ulcerated lesions in a patient with cutaneous myeloid sarcoma responded to twice-daily fludarabine and cytarabine regimen. Blood Cells Mol Dis 69:43-44, 2018. e-Pub 2018. PMID: 28624256.
Tetzlaff MT, Nelson KC, Diab A, Staerkel GA, Nagarajan P, Torres-Cabala CA, Chasen BA, Wargo JA, Prieto VG, Amaria RN, Curry JL. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. J Immunother Cancer 6(1):14, 2018. e-Pub 2018. PMID: 29433571.
Jour G, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CA. Differential expression of CCR4 in primary cutaneous gamma/delta (γ/δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy. J Dermatol Sci 89(1):88-91, 2018. e-Pub 2018. PMID: 29030090.
Chan WH, Lewis DJ, Hinojosa T, Curry JL, Duvic M. Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation. Pediatr Dermatol 35(1):e13-e16, 2018. e-Pub 2018. PMID: 29159918.
Kandl TJ, Sagiv O, Curry JL, Ning J, Ma J, Hudgens CW, Van Arnam J, Wargo JA, Esmaeli B, Tetzlaff MT. High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma. Oncoimmunology 7(9):e1475874, 2018. e-Pub 2018. PMID: 30228943.
Tetzlaff MT, Jazaeri AA, Torres-Cabala CA, Korivi BR, Landon GA, Nagarajan P, Choksi A, Chen L, Uemura M, Aung PP, Diab A, Sharma P, Davies MA, Amaria R, Prieto VG, Curry JL. Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients. J Cutan Pathol 44(12):1080-1086, 2017. e-Pub 2017. PMID: 28901560.
Loghavi S, Curry JL, Garcia-Manero G, Patel KP, Xu J, Khoury JD, Torres-Cabala CA, Nagarajan P, Aung PP, Gibson BR, Goodwin BP, Kelly BC, Korivi BR, Medeiros LJ, Prieto VG, Kantarjian HM, Bueso-Ramos CE, Tetzlaff MT. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia. J Cutan Pathol 44(12):1075-1079, 2017. e-Pub 2017. PMID: 28885734.
Ramani N, Aung PP, Hwu WJ, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Torres-Cabala CA. Aberrant Expression of FLI-1 in Melanoma. J Cutan Pathol 44(9):790-793, 2017. e-Pub 2017. PMID: 28605142.
Shustef E, Torres-Cabala CA, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Aung PP. Intraepithelial Melanoma in the Stomach After Treatment With Immune Checkpoint Blockade Therapy. Am J Dermatopathol 39(8):e116-e118, 2017. e-Pub 2017. PMID: 28248716.
Jour G, Aung PP, Rozas-Muñoz E, Curry JL, Prieto V, Ivan D. Intraepidermal Merkel cell carcinoma: a case series of a rare entity with clinical follow-up. J Cutan Pathol 44(8):684-691, 2017. e-Pub 2017. PMID: 28543532.
Konopinski J, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PP. Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor. Am J Dermatopathol 39(7):545-547, 2017. e-Pub 2017. PMID: 28178009.
Aung PP, Rady PL, Nagarajan P, Ivan D, Tetzlaff MT, Curry JL, Tyring SK, Prieto VG, Torres-Cabala CA. Detection of Merkel Cell Polyoma Virus and Beta Human Papillomavirus in Multiple Eccrine Poromas in a Patient With Acute Leukemia Treated With Stem Cell Transplant. Am J Dermatopathol 39(6):489-491, 2017. e-Pub 2017. PMID: 27655121.
Valero-Torres A, Prieto VG, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall. Am J Dermatopathol 39(6):468-470, 2017. e-Pub 2017. PMID: 28525424.
Nagarajan P, Curry JL, Ning J, Piao J, Torres Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto V, Tetzlaff MT. Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: A retrospective review of 100 cases. Clin Cancer Res 23(8):2093-2104, 2017. e-Pub 2017. PMID: 27864417.
Chakravarti N, Ivan D, Trinh VA, Glitza IC, Curry JL, Torres-Cabala C, Tetzlaff MT, Bassett RL, Prieto VG, Hwu WJ. High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients. Melanoma Res 27(1):24-31, 2017. e-Pub 2017. PMID: 27768639.
Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas. Am J Surg Pathol 41(2):204-215, 2017. e-Pub 2017. PMID: 27879514.
Tetzlaff MT, Nagarajan P, Chon S, Huen A, Diab A, Omar P, Aung PP, Torres-Cabala CA, Mays SR, Prieto VG, Curry JL. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. Am J Dermatopathol 39(2):121-129, 2017. e-Pub 2017. PMID: 28134729.
Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG. Clinical Significance of BRAF V600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma. Hum Pathol 59:48-54, 2017. e-Pub 2017. PMID: 27666765.
Nagarajan P, Tetzlaff MT, Curry JL, Prieto VG. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry. Actas Dermosifiliogr, 2017. e-Pub 2017. PMID: 27344067.
Uemura M, Fa'ak F, Haymaker C, McQuail N, Sirmans E, Hudgens CW, Barbara L, Bernatchez C, Curry JL, Hwu P, Tetzlaff MT, Diab A. Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1. J Immunother Cancer 5(1):7, 2017. e-Pub 2017. PMID: 28116090.
Honarpisheh HH, Curry JL, Richards K, Nagarajan P, Aung PP, Torres-Cabala CA, Ivan D, Drucker CR, Cartun R, Prieto VG, Tetzlaff MT. Cutaneous histoplasmosis with prominent parasitization of epidermal keratinocytes: report of a case. J Cutan Pathol 43(12):1155-1160, 2016. e-Pub 2016. PMID: 27516534.
Al-Rohil RN, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, Curry JL, Miranda RN, Duvic M, Prieto VG, Aung PP. Loss of CD30 expression after treatment with Brentuximab Vedotin in a patient with Anaplastic Large Cell Lymphoma: a novel finding. J Cutan Pathol 43(12):1161-1166, 2016. e-Pub 2016. PMID: 27531242.
Feldmeyer L, Hudgens CW, Lyons GR, Nagarajan P, Aung PP, Curry JL, Torres Cabala CA, Mino B, Rodriguez-Canales J, Reuben A, Chen PL, Ko JS, Billings SD, Bassett RL, Wistuba II, Cooper ZA, Prieto VG, Wargo JA, Tetzlaff MT. Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma. Clin Cancer Res 22(22):5553-5563, 2016. e-Pub 2016. PMID: 27166398.
Ramani NS, Curry JL, Merrill ED, Aung PP, Prieto V, Tetzlaff MT, Duvic M, Miranda R, Torres-Cabala C. Primary Cutaneous Gamma-Delta (γ/δ) T-cell Lymphoma: An Unusual Case With Very Subtle Histopathological Findings. Am J Dermatopathol 38(10):e147-e149, 2016. e-Pub 2016. PMID: 27533072.
Uemura, M, Faak, F, Haymaker, CL, McQuail, N, Sirmans, E, Hudgens, CW, Barbara, L, Bernatchez, C, Curry, JL, Hwu, P, Tetzlaff, M, Diab, A. A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1. Journal for immunotherapy of cancer 4(1), 2016. e-Pub 2016. PMID: 27660709.
Tetzlaff MT, Singh RR, Seviour EG, Curry JL, Hudgens CW, Bell D, Wimmer DA, Ning J, Czerniak BA, Zhang L, Davies MA, Prieto VG, Broaddus RR, Ram P, Luthra R, Esmaeli B. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol 240(1):84-95, 2016. e-Pub 2016. PMID: 27287813.
Ravishankar S, Nagarajan P, Curry JL, Tetzlaff MT, Ivan D, Torres-Cabala CA, Aung PP, Prieto VG. Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas. J Cutan Pathol 43(8):722-724, 2016. e-Pub 2016. PMID: 27124588.
Jour G, Glitza IC, Ellis RM, Torres-Cabala CA, Tetzlaff MT, Li JY, Nagarajan P, Huen A, Aung PP, Ivan D, Drucker CR, Prieto VG, Rapini RP, Patel A, Curry JL. Autoimmune Dermatologic Toxicities from Immune Checkpoint Blockade with anti-PD-1 Antibody Therapy: A Report on Bullous Skin Eruptions. J Cutan Pathol 43(8):688-696, 2016. e-Pub 2016. PMID: 27086658.
Feldmeyer L, Tetzlaff M, Fox P, Nagarajan P, Curry J, Ivan D, Torres Cabala CA, Prieto VG, Aung PP. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma. Am J Dermatopathol 38(7):484-491, 2016. e-Pub 2016. PMID: 26675354.
Al-Rohil RN, Curry JL, Torres-Cabala CA, Nagarajan P, Ivan D, Aung PP, Ray GF, Bassett RL, Prieto VG, Tetzlaff MT. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Hum Pathol 53:73-81, 2016. e-Pub 2016. PMID: 27004944.
Napoli M, Venkatanarayan A, Raulji P, Meyers BA, Norton W, Mangala LS, Sood AK, Rodriguez-Aguayo C, Lopez-Berestein G, Vin H, Duvic M, Tetzlaff MB, Curry JL, Rook AH, Abbas HA, Coarfa C, Gunaratne PH, Tsai KY, Flores ER. Delta Np63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer. Cancer Cell 29(6):874-88, 2016. e-Pub 2016. PMID: 27300436.
Mudaliar K, Tetzlaff MT, Duvic M, Ciurea A, Hymes S, Milton DR, Tsai KY, Prieto VG, Torres-Cabala CA, Curry JL. BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Hum Pathol 50:79-89, 2016. e-Pub 2016. PMID: 26997441.
Danialan R, Tetzlaff MT, Torres-Cabala CA, Mays SR, Prieto VG, Bell D, Curry JL. Cutaneous metastasis from anaplastic thyroid carcinoma exhibiting exclusively a spindle cell morphology. A case report and review of literature. J Cutan Pathol 43(3):252-257, 2016. e-Pub 2016. PMID: 26347145.
Schlichte MJ, Talpur R, Venkatarajan S, Curry JL, Nagarajan P, Duvic M. Verrucous presentation in patients with mycosis fungoides. Int J Dermatol 55(3):e126-e129, 2016. e-Pub 2016. PMID: 26519087.
Feldmeyer L, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Bell D, Moon BS, Torres-Cabala CA, Aung PP. Role of Radiotherapy in Aggressive Digital Papillary Adenocarcinoma. Ann Clin Lab Sci 46(2):222-4, 2016. e-Pub 2016. PMID: 27098633.
Oh CW, Ivan D, Curry J, Ellis R, Gerber H, Duvic M, Torres-Cabala C. A Case of Indeterminate Dendritic Cell Tumor Presenting with Leonine Facies. J Cutan Pathol 43(2):158-163, 2016. e-Pub 2016. PMID: 26272726.
Estrella JS, Tetzlaff M, Bassett RL, Patel KP, Williams MD, Curry J, Rashid A, Hamilton SR, Broaddus RR. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing. Mol Cancer Ther 14(12):2887-2895, 2015. e-Pub 2015. PMID: 26438153.
Goldstein J, Patel AB, Curry JL, Subbiah V, Piha-Paul S. Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report. BMC Dermatol 15(1):22, 2015. e-Pub 2015. PMID: 25778951.
Tetzlaff MT, Curry JL, Yin V, Pattanaprichakul P, Manonukul J, Uiprasertkul M, Manyam GC, Wani KM, Aldape K, Zhang L, Prieto VG, Esmaeli B. Distinct Pathways in the Pathogenesis of Sebaceous Carcinomas Implicated by Differentially Expressed MicroRNAs. JAMA Ophthalmol 133(10):1109-1116, 2015. e-Pub 2015. PMID: 26203913.
Ramani NS, Curry JL, Kapil J, Rapini RP, Tetzlaff MT, Prieto VG, Torres-Cabala CA. Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma. Am J Dermatopathol 37(8):e96-e99, 2015. e-Pub 2015. PMID: 25839886.
Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PP, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL. Utility of BRAF V600E immunohistochemical expression pattern as a surrogate of BRAF mutation status in 154 patients with advanced melanoma. Hum Pathol 46(8):1101-1110, 2015. e-Pub 2015. PMID: 26058727.
Yin VT, Wiraszka TA, Tetzlaff M, Curry JL, Esmaeli B. Cutaneous Eyelid Neoplasms as a Toxicity of Vemurafenib Therapy. Ophthal Plast Reconstr Surg 31(4):e112-e115, 2015. e-Pub 2015. PMID: 24833447.
Wang WL, Torres-Cabala C, Curry J, Ivan D, McLemore M, Tetzlaff M, Zembowicz A, Prieto VG, Lazar AJ. Metastatic Atypical Fibroxanthoma: A Series of 11 Cases Including With Minimal and No Subcutaneous Involvement. Am J Dermatopathol 37(6):455-461, 2015. e-Pub 2015. PMID: 25590287.
Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT. Use of Clinical Next-Generation Sequencing To Identify Melanomas Harboring SMARCB1 Mutations. J Cutan Pathol 42(5):308-317, 2015. e-Pub 2015. PMID: 25754356.
de la Garza Bravo MM, Patel KP, Loghavi S, Curry JL, Torres Cabala CA, Cason RC, Gangar P, Prieto VG, Medeiros LJ, Duvic M, Tetzlaff MT. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. Hum Pathol 46(4):558-569, 2015. e-Pub 2015. PMID: 25666664.
Torres-Cabala CA, Curry JL, Li Ning Tapia EM, Ramos C, Tetzlaff MT, Prieto VG, Miranda RN, Bravo F. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci 77(3):150-155, 2015. e-Pub 2015. PMID: 25676425.
Goldstein J, Patel AB, Curry JL, Subbiah V, Piha-Paul S. Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report. BMC Dermatol 15:2, 2015. e-Pub 2015. PMID: 25886034.
Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol 135(2):508-515, 2015. e-Pub 2015. PMID: 25148578.
Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, Tsai KY, Curry J, Tetzlaff MT, Lai SY, Yu J, Muzny DM, Doddapaneni H, Shinbrot E, Covington KR, Zhang J, Seth S, Caulin C, Clayman GL, El-Naggar AK, Gibbs RA, Weber RS, Myers JN, Wheeler DA, Frederick MJ. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res 20(24):6582-6592, 2014. e-Pub 2014. PMID: 25303977.
Henderson SA, Tetzlaff MT, Pattanaprichakul P, Fox P, Torres-Cabala CA, Bassett RL, Prieto VG, Richards HW, Curry JL. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma. J Cutan Pathol 41(11):846-852, 2014. e-Pub 2014. PMID: 25263506.
Henderson SA, Torres-Cabala CA, Curry JL, Bassett RL, Ivan D, Prieto VG, Tetzlaff MT. p40 Is More Specific Than p63 for the Distinction of Atypical Fibroxanthoma From Other Cutaneous Spindle Cell Malignancies. Am J Surg Pathol 38(8):1102-10, 2014. e-Pub 2014. PMID: 25029117.
Curry JL, Tetzlaff MT, Nicholson K, Duvic M, Kim KB, Tsai KY, Hwu WJ, Hong DS, Prieto VG, Torres-Cabala CA. Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy. Am J Dermatopathol 36(7):557-61, 2014. e-Pub 2014. PMID: 24950418.
De la Garza Bravo MM, Curry JL, Torres-Cabala CA, Ivan DS, Drucker C, Prieto VG, Tetzlaff MT. Pigmented extramammary Paget disease of the thigh mimicking a melanocytic tumor: report of a case and review of the literature. J Cutan Pathol 41(6):529-535, 2014. e-Pub 2014. PMID: 24698435.
Nadeem S, Hymes S, Kebriaei P, Abruzzo L, Curry JL, Duvic M. Alopecia areata after HLA-identical BMT from an affected, sibling donor. Bone Marrow Transplant 49(4):592-4, 2014. e-Pub 2014. PMID: 24442249.
Curry JL, Torres-Cabala CA, Kim KB, Tetzlaff MT, Duvic M, Tsai KY, Hong DS, Prieto VG. Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions. Int J Dermatol 53(3):376-384, 2014. e-Pub 2014. PMID: 23879247.
Pattanaprichakul P, Tetzlaff MT, Lapolla WJ, Torres-Cabala CA, Duvic M, Prieto VG, Tsai KY, Curry JL. Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma. J Cutan Pathol 41(3):326-8, 2014. e-Pub 2014. PMID: 24372055.
McQuitty E, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala C. CD8-positive ("type D") lymphomatoid papulosis and its differential diagnosis. J Cutan Pathol 41(2):88-100, 2014. e-Pub 2014. PMID: 24118002.
Aung PP, Climent F, Muzzafar T, Curry JL, Patel KP, Servitje O, Prieto VG, Duvic M, Jaffe ES, Torres-Cabala CA. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of 3 cases. J Cutan Pathol 41(1):51-57, 2014. e-Pub 2014. PMID: 24151865.
Loghavi S, Curry JL, Torres-Cabala CA, Ivan D, Patel KP, Mehrotra M, Bassett R, Prieto VG, Tetzlaff MT. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature. Mod Pathol 27(11):1468-1478, 2014. e-Pub 2014. PMID: 24743221.
Wright NA, Torres-Cabala CA, Curry JL, Cutlan JE, Hymes SR. Post-varicella-zoster virus granulomatous dermatitis: a report of 2 cases. Cutis 93(1):50-4, 2014. e-Pub 2014. PMID: 24505586.
Curry JL, Davies MA, Calderone TL, Nathanson K, Prieto VG, Gershenwald JE. Tissue resources for clinical use and marker studies in melanoma. Methods Mol Biol 1102:679-95, 2014. e-Pub 2014. PMID: 24259006.
Bunata K, Jahan-Tigh RR, Curry J, Duvic M. A verrucous presentation of mycosis fungoides. Dermatol Online J 20(8), 2014. e-Pub 2014. PMID: 25148274.
Kim CY, Kim DW, Kim K, Curry J, Torres-Cabala C, Patel S. GNAQ mutation in a patient with metastatic mucosal melanoma. BMC Cancer 14(1):516, 2014. e-Pub 2014. PMID: 25030020.
Tetzlaff MT, Wang WL, Milless TL, Curry JL, Torres-Cabala CA, McLemore MS, Ivan D, Bassett RL, Prieto VG. Ambiguous Melanocytic Tumors in a Tertiary Referral Center: The Contribution of Fluorescence In Situ Hybridization (FISH) to Conventional Histopathologic and Immunophenotypic Analyses. Am J Surg Pathol 37(12):1783-1796, 2013. e-Pub 2013. PMID: 24061523.
Merritt BY, Curry JL, Duvic M, Vega F, Sheehan AM, Curry CV. Pediatric subcutaneous panniculitis-like T-cell lymphoma with features of hemophagocytic syndrome. Pediatr Blood Cancer 60(11):1916-1917, 2013. e-Pub 2013. PMID: 23868752.
Bucheit AD, Syklawer E, Jakob JA, Bassett RL, Curry JL, Gershenwald JE, Kim KB, Hwu P, Lazar AJ, Davies MA. Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma. Cancer 119(21):3821-3829, 2013. e-Pub 2013. PMID: 23922205.
Mays R, Curry J, Kim K, Tsai K, Arora A, Khan F, Ramirez-Fort M, Ciurea A. Eruptive squamous cell carcinomas after vemurafenib therapy. J Cutan Med Surg 17(6):419-22, 2013. e-Pub 2013. PMID: 24138980.
Shiue LH, Ni X, Prieto VG, Jorgensen JL, Curry JL, Goswami M, Sweeney SA, Duvic M. A case of invisible leukemic cutaneous T cell lymphoma with a regulatory T cell clone. Int J Dermatol 52(9):1111-1114, 2013. e-Pub 2012. PMID: 22257096.
Tetzlaff MT, Curry JL, Ivan D, Wang WL, Torres-Cabala CA, Bassett RL, Valencia KM, McLemore MS, Ross MI, Prieto VG. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Mod Pathol 26(9):1-8, 2013. e-Pub 2013. PMID: 23558574.
Curry JL, Falchook GS, Hwu WJ, Torres-Cabala CA, Duvic M, Tetzlaff MT, Prieto VG. Changes in Tumor Morphology and Cyclin-Dependent Kinase Inhibitor Expression in Metastatic Melanoma Treated With Selective Second-Generation BRAF Inhibitor. Am J Dermatopathol 35(1):125-128, 2013. e-Pub 2012. PMID: 22878367.
Vin H, Ching G, Ojeda SS, Adelmann CH, Chitsazzadeh V, Dwyer DW, Ma H, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Ciurea AM, Duvic M, Busaidy NL, Tannir NM, Tsai KY. Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK. Mol Cancer Ther 13(1):221-229, 2013. e-Pub 2013. PMID: 24170769.
Chu VH, Tetzlaff MT, Torres-Cabala CA, Prieto VG, Bassett R, Gershenwald JE, McLemore MS, Ivan D, Wang WL, Ross MI, Curry JL. Impact of the 2009 (7th Edition) AJCC Melanoma Staging System in the Classification of Thin Cutaneous Melanomas. Biomed Res Int 2013:898719, 2013. e-Pub 2013. PMID: 24369020.
Vin H, Ojeda SS, Ching G, Leung ML, Chitsazzadeh V, Dwyer DW, Adelmann CH, Restrepo M, Richards KN, Stewart LR, Du L, Ferguson SB, Chakravarti D, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Kim KB, Ciurea AM, Duvic M, Prieto VG, Ullrich SE, Dalby KN, Flores ER, Tsai KY. BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling. Elife 2(0), 2013. e-Pub 2013. PMID: 24192036.
Curry JL, Torres-Cabala CA, Tetzlaff MT, Bowman C, Prieto VG. Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma. Semin Cutan Med Surg 31(4):267-73, 2012. e-Pub 2012. PMID: 23174497.
Curry CV, Konoplev SN, Torres-Cabala C, Alousi A, Duvic M, Curry JL. Blastic Plasmacytoid Dendritic Cell Neoplasm with Leukemic Progression. Journal of Medical Cases 3(6):337-339, 2012. e-Pub 2012.
Curry JL, Torres-Cabala CA, Warneke CL, Zhang P, Prieto VG. Distinct Subcellular Localization of GSK-3β in Melanocytic Nevi: Implications in Melanocyte Senescence. OJ Pathology 2:113-119, 2012. e-Pub 2012.
Rose CL, Chakravarti N, Curry JL, Torres-Cabala CA, Bassett R, Prieto VG, Tetzlaff MT. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms. J Cutan Pathol 39(8):762-8, 2012. e-Pub 2012. PMID: 22764884.
Jakob JA, Bassett RL, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, Lazar AJ, Hwu P, Davies MA. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer 118(16):4014-23, 2012. e-Pub 2012. PMID: 22180178.
Zhang YH, Wang WL, Rapini RP, Torres-Cabala C, Prieto VG, Curry JL. Syringocystadenocarcinoma Papilliferum With Transition to Areas of Squamous Differentiation: A Case Report and Review of the Literature. Am J Dermatopathol 34(4):428-33, 2012. e-Pub 2012. PMID: 22343110.
McLemore MS, Bruner JM, Curry JL, Prieto VG, Torres-Cabala CA. Anaplastic oligodendroglioma involving the subcutaneous tissue of the scalp: Report of an exceptional case and review of the literature. Am J Dermatopathol 34(2):214-9, 2012. e-Pub 2012. PMID: 22157246.
Martinez DR, Richards HW, Lin Q, Torres-Cabala CA, Prieto VG, Curry JL, Medrano EE. H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma. J Skin Cancer 2012(Article ID 823534):9 pages, 2012. e-Pub 2012. PMID: 23227340.
McLemore MS, Huo L, Deavers MT, Curry JL, Torres-Cabala CA, Wang WL, Prieto VG. Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall. J Cutan Pathol 38(10):818-22, 2011. e-Pub 2011. PMID: 21752053.
Curry, JL, Falchook, GS, Torres Cabala, CA, Tetzlaff, M, Prieto, V. Resistant mechanisms to BRAF inhibitor PLX4032 in melanoma. Expert Review of Dermatology 6(4):355-357, 2011. e-Pub 2011.
Curry JL, Prieto VG, Jones DM, Vega F, Duvic M, Diwan AH. Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome. J Cutan Pathol 38(3):295-7, 2011. e-Pub 2011. PMID: 19889052.
Bi MY, Curry JL, Christiano AM, Hordinsky MK, Norris DA, Price VH, Duvic M. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome. J Am Acad Dermatol 64(1):53-63, 2011. e-Pub 2011. PMID: 21036417.
Curry JL, Richards HW, Huttenbach YT, Medrano EE, Reed JA. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes. J Cutan Pathol 36(2):197-205, 2009. e-Pub 2009. PMID: 18647205.
Curry JL, Goulder SJ, Nickoloff BJ. Occurrence of a basal cell carcinoma and dermatofibroma in a smallpox vaccination scar. Dermatol Surg 34(1):132-3; discussion 133-4, 2008. e-Pub 2008. PMID: 18053037.
Bandyopadhyay D, Curry JL, Lin Q, Richards HW, Chen D, Hornsby PJ, Timchenko NA, Medrano EE. Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell 6(4):577-91, 2007. e-Pub 2007. PMID: 17578512.
Rubenstein MA, Farnsworth NN, Pielop JA, Orengo IF, Curry JL, Drucker CR, Hsu S. Cutaneous Rosai-Dorfman disease. Dermatol Online J 12(1):8, 2006. e-Pub 2006. PMID: 16638376.
Chaturvedi V, Sitailo LA, Qin JZ, Bodner B, Denning MF, Curry J, Zhang W, Brash D, Nickoloff BJ. Knockdown of p53 levels in human keratinocytes accelerates Mcl-1 and Bcl-x(L) reduction thereby enhancing UV-light induced apoptosis. Oncogene 24(34):5299-312, 2005. e-Pub 2005. PMID: 15940268.
Quinn AM, Brown K, Bonish BK, Curry J, Gordon KB, Sinacore J, Gamelli R, Nickoloff BJ. Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis. Arch Dermatol 141(6):683-7, 2005. e-Pub 2005. PMID: 15967913.
Nickoloff BJ, Lingen MW, Chang BD, Shen M, Swift M, Curry J, Bacon P, Bodner B, Roninson IB. Tumor suppressor maspin is upregulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Res 64(9):2956-61, 2004. e-Pub 2004. PMID: 15126325.
Curry JL, Wojcik EM. Malignant pericardial effusion with metastatic squamous-cell carcinoma: discordance between ThinPrep and cell-block cytopreparation. Diagn Cytopathol 29(5):270, 2003. e-Pub 2003. PMID: 14595794.
Xin H, Curry J, Johnstone RW, Nickoloff BJ, Choubey D. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Oncogene 22(31):4831-40, 2003. e-Pub 2003. PMID: 12894224.
Curry JL, Qin JZ, Robinson J, Nickoloff BJ. Reactivity of resident immunocytes in normal and prepsoriatic skin using an ex vivo skin-explant model system. Arch Pathol Lab Med 127(3):289-96, 2003. e-Pub 2003. PMID: 12653571.
Curry JL, Qin JZ, Bonish B, Carrick R, Bacon P, Panella J, Robinson J, Nickoloff BJ. Innate immune-related receptors in normal and psoriatic skin. Arch Pathol Lab Med 127(2):178-86, 2003. e-Pub 2003. PMID: 12562231.
Curry JL, Wojcik EM. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Cancer 96(3):140-5, 2002. e-Pub 2002. PMID: 12115301.
Picken MM, Curry JL, Lindgren V, Clark JI, Eble JN. Metanephric adenosarcoma in a young adult: morphologic, immunophenotypic, ultrastructural, and fluorescence in situ hybridization analyses: a case report and review of the literature. Am J Surg Pathol 25(11):1451-7, 2001. e-Pub 2001. PMID: 11684965.
Curry JL, Olejnik JL, Wojcik EM. Cellular angiofibroma of the vulva with DNA ploidy analysis. Int J Gynecol Pathol 20(2):200-3, 2001. e-Pub 2001. PMID: 11293169.
Curry JL, Pinto W, Nickoloff BJ, Slominski AT. Human keratinocytes express functional alpha-MSH (MC1-R) receptors. In Vitro Cell Dev Biol Anim 37(4):234-236, 2001. e-Pub 2001. PMID: 11409689.
Omeroglu, A, Curry, JL, Wojcik, EM, Hartman, G. Extraskeletal mesenchymal chondrosarcoma metastatic to the posterior mediastinum showing strong co-expression of CD99 and Bcl-2. Journal of Histotechnology 24(2):117-119, 2001. e-Pub 2001.
Omeroglu A, Curry J, Wojcik EM, Hartman G. Extraskeletal mesenchymal chondrosarcoma metastatic to the posterior mediastinum showing strong co-expression of CD99 and Bcl-2: A case report with immunohistochemical studies, differential diagnosis and literature review. J Histotechnol:24, 2001. e-Pub 2001.
Slominski, AT, Roloff, B, Zbytek, B, Wei, ET, Fechner, K, Curry, JL, Wortsman, J. Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cellular and Developmental Biology - Animal 36(3):211-216, 2000. e-Pub 2000. PMID: 10777063.
Slominski, AT, Roloff, B, Curry, JL, Dahiya, M, Szczesniewski, A, Wortsman, J. The skin produces urocortin. Journal of Clinical Endocrinology and Metabolism 85(2):815-823, 2000. e-Pub 2000. PMID: 10690896.
Slominski AT, Roloff B, Zbytek B, Wei ET, Fechner K, Curry J. Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol Anim 63(3):211-216, 2000. e-Pub 2000.
Slominski A, Roloff B, Curry J. The skin produces urocortin. J Clin Endocrinol Metab 85(2):815-832, 2000. e-Pub 2000.

Invited Articles

Curry JL, Falchook GS, Torres-Cabala CA, Tetzlaff MT, Prieto VG. Resistant mechanisms to BRAF inhibitor PLX4032 in melanoma. Expert Review of Dermatology 6(4):355-357, 2011. e-Pub 2011.

Review Articles

Gill P, Middleton L, Zhang J, Keiser E, Ding QQ, Li Z, Duose D, Hernandez S, Arrechedera C, Aung P, Torres-Cabala CA, Curry JL, Cho WC, Prieto VG, Ivan D, Nagarajan P. Comparative Transcriptomic Analyses Distinguish Cutaneous Squamoid Eccrine Ductal Carcinomas from Low-Grade Adenosquamous Carcinomas of the Breast. Modern Pathology 103(3):403-404, 2023. e-Pub 2023.
Seervai RNH, Friske SK, Chu EY, Phillips R, Nelson KC, Huen A, Cho WC, Aung PP, Torres-Cabala CA, Prieto VG, Curry JL. The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapy. J Cutan Pathol 50(1):72-95, 2023. e-Pub 2023. PMID: 36069496.
Seervai RNH, Cho WC, Chu EY, Marques-Piubelli ML, Ledesma DA, Richards K, Heberton MM, Nelson KC, Nagarajan P, Torres-Cabala CA, Prieto VG, Curry JL. Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy. J Cutan Pathol 49(1):61-81, 2022. e-Pub 2022. PMID: 34622477.
Gill P, Richards K, Cho WC, Nagarajan P, Aung PP, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Localized cutaneous argyria: Review of a rare clinical mimicker of melanocytic lesions. Ann Diagn Pathol 54:151776, 2021. e-Pub 2021. PMID: 34214703.
Curry JL, Chon SY, Marques-Piubelli ML, Chu EY. Cutaneous Toxicities in the Setting of Immune Checkpoint Blockade:: The Era of Oncodermatopathology. Surg Pathol Clin 14(2):209-224, 2021. e-Pub 2021. PMID: 34023101.
Ruiz SJ, Al Salihi S, Prieto VG, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Aung PP. Unusual cutaneous metastatic carcinoma. Ann Diagn Pathol 43:151399, 2019. e-Pub 2019. PMID: 31675677.
Ronen S, Ivan D, Torres-Cabala CA, Curry JL, Tetzlaff MT, Aung PP, Nagarajan P, Suster S, Prieto VG. Post-radiation vascular lesions of the breast. J Cutan Pathol 46(1):52-58, 2019. e-Pub 2019. PMID: 30251277.
Tetzlaff MT, Reuben A, Billings SD, Prieto VG, Curry JL. Toward a Molecular-Genetic Classification of Spitzoid Neoplasms. Clin Lab Med 37(3):431-448, 2017. e-Pub 2017. PMID: 28802494.
Curry JL, Tetzlaff MT, Nagarajan P, Drucker C, Diab A, Hymes SR, Duvic M, Hwu WJ, Wargo JA, Torres-Cabala CA, Rapini RP, Prieto VG. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol 44(2):158-176, 2017. e-Pub 2017. PMID: 27859479.
Curry JL. Emerging clinical applications of selected biomarkers in melanoma. Clin Cosmet Investig Dermatol 8:35-46, 2015. e-Pub 2015. PMID: 25674009.
Rubenstein MC, Martinelli PT, Bayer-Garner IB, Klebuc MJ, Curry JL, Hsu S. Persistent cutaneous manifestations of hyperoxaluria after combined hepatorenal transplantation. Dermatol Online J 10(1):10, 2004. e-Pub 2004. PMID: 15347492.
Curry JL, Petruzzelli GJ, McClatchey KD, Lingen MW. Synchronous benign and malignant salivary gland tumors in ipsilateral glands: a report of two cases and a review of literature. Head Neck 24(3):301-6, 2002. e-Pub 2002. PMID: 11891964.

Professional Educational Materials

Curry JL, Omeroglu A, Husain AN. Pulmonary coccidioidomycosis, 2002.

Abstracts

Irfan A, Khazaeli M, Milton D, Nagarajan P, Lenskaya V, Cho WC, Curry JL, Torres-Cabala CA, Prieto VG, Yang R, Aung P. PD-L1 (CD274) Gene Alteration in Melanoma: Relationship to immunotherapy, disease progression and tumor mutation burden. 2025 Annual USCAP Meeting, 2025. e-Pub 2025.
Do J, Wang, Y, Aung P, Nagarajan P, Ning J, Curry JL, Ivan D, Lenskaya V, Torres-Cabala CA, Prieto VG, Choo WC. INSM1: A Highly Sensitive Marker for Primary and Metastatic Merkel Cell Carcinoma, Superior to SOX11, Pancytokeratin, and CK20. 2025 Annual USCAP Meeting, 2025. e-Pub 2025.
Khazaeli M, Irfan A, Nagarajan P, Curry JL, Prieto VG, Cho WC, Huen A, Torres-Cabala CA. Pathological and Clinical Features of Lymphomatoid Papulosis in Children and Adolescents from a Tertiary Cancer Center. 2025 Annual USCAP Meeting, 2025. e-Pub 2025.
Ibrahim E, Yang R, Nagarajan P, Sweeney K, Chen H, Roy-Chowdhuri S, Lenskaya V, Aung P, Curry JL, Ivan D, Prieto VG, Torres-Cabala CA, Cho WC. Clinicopathologic and Molecular Characterization of BRAF-Fused Melanomas: A Retrospective Analysis of 9 Cases with 8 Novel Fusions Detected by Next-Generation Sequencing. 2025 Annual USCAP Meeting, 2025. e-Pub 2025.
Hegazy S, Curry JL, Dai J, Tang G, Muhaj F, Huen A, Nagarajan P, Aung P, Prieto VG, Vega F, Medeiros LJ, Torres-Cabala CA, Cho WC. Primary Cutaneous CD30-Positive Lymphoproliferative Disorders with IRF4/DUSP22-Associated Chromosomal Alterations, including Rearrangements, Gains, and Deletions: A Clinicopathological, Immunohistochemical, and Molecular Analysis of 22 Patients. 2025 Annual USCAP Meeting, 2025. e-Pub 2025.
He L, Wang Y, Curry JL, Ning J, Aung P, Nagarajan P, Prieto VG, Torres-Cabala CA, Cho WC. TROP2 is Highly Expressed in Cutaneous Squamous Cell Carcinomas and a Subset of Adnexal Carcinomas: A Potential Therapeutic Target with TROP2-Directed Antibody Drug Conjugates. 2025 Annual USCAP Meeting, 2025. e-Pub 2025.
Kim MJ, Curry JL, Yang R, Nagarajan P, Aung P, Woo Cheal Cho. Identification of Novel Fusions in Melanoma by Next-Generation Sequencing: A Retrospective Analysis of 144 Patients from a Single Tertiary Cancer Center. 2024 USCAP Annual Meeting 104(1):S531-S533, 2024. e-Pub 2024.
Lenskaya V, Wang Y, Malpica A, Pettaway C, Ning J, Torres-Cabala CA, Curry JL, Aung P, Cho WC, Ivan D, Prieto VG, Gershenwald J, Davies M, Futreal A, McQuade J, Nagarajan P. Primary Female Urethral Mucosal Melanoma: Retrospective Analysis of Clinicopathological and Molecular Features. 2024 USCAP Annual Meeting 104(1):S535-S536, 2024. e-Pub 2024.
Alkamachi B, Gill P, Soto LS, Lenskaya V, Lu W, Khan K, Tarrand J, Aung P, Torres-Cabala CA, Woo CC, Curry JL, Ivan D, Prieto VG, Nagarajan P. Optimizing Immunohistochemical Detection for Histologic Diagnosis of Fusariosis. 2024 USCAP Annual Meeting 104(1):S1535-S1536, 2024. e-Pub 2024.
Liu Y, Torres-Cabala CA, Wang D, Shah M, Cho WC, Nagarajan P, Curry JL, Ivan D, Prieto VG, Ballester L, Aung P. Metabolic Profiling in Acral Melanomas Reveals Key Metabolic Pathway Gene Differences Compared with Non-acral Melanomas 103(3):412-413, 2023. e-Pub 2023.
Liu Y, Aung P, Ding QQ, Nagarajan P, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG, Cho WC. TRPS1 May be an Effective Discriminatory Marker for Basal Cell Carcinoma and Squamous Cell Carcinoma: An Immunohistochemical Analysis of TRPS1 in Non-Melanocytic Cutaneous Neoplasms 103(3):413-414, 2023. e-Pub 2023.
Rahbar, Z, Aung P, Shen L, Yang R, Zambrano SC, Castaneda C, Castillo M, Pattanaprichakul P, Cho WC, Nagarajan P, Wang J, Prieto VG, Curry JL, Torres-Cabala CA. Whole Exome Sequencing of Acral Lentiginous Melanoma Reveals Novel Somatic Mutations and Potential Differences in Patients from Different Ethnicites 103(3):427-428, 2023. e-Pub 2023.
Gill P, Middleton L, Zhang J, Keiser E, Ding QQ, Li Z, Duose D, Hernandez S, Arrechedera C, Aung P, Torres-Cabala CA, Curry JL, Cho WC, Prieto VG, Ivan D, Nagarajan P. Comparative Transcriptomic Analyses Distinguish Cutaneous Squamoid Eccrine Ductal Carcinomas from Low-Grade Adenosquamous Carcinomas of the Breast 103(3):403-404, 2023. e-Pub 2023.
Dimopoulos YP, Cunningham C, Wang WL, Ingram D, Lazcano R, Nagarajan P, Curry JL, Torres-Cabala CA, Prieto VG, Cho WC, Aung P. Vascular Changes in Merkel Cell Carcinoma: Prevalence, Association with Local VEGF Expression, and Prognostic Implications 103(3):398-399, 2023. e-Pub 2023.
Aung P, Gill P, Lai Z, Zhu K, Vasudevaraja V, Ivan D, Nagarajan P, Cho WC, Ballester L, Curry JL, Torres-Cabala CA, Prieto VG, Jour G. Multi-omics Analysis of Digital Papillary Adenocarcinoma Reveals Upregulation of MAGEA4 and Infrequent Zinc Finger Genes Rearrangements, 2022. e-Pub 2022.
Gill P, John TM, Tarrand J, Jiang X, Ning J, Aung P, Cho WC, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Nagarajan P. Cutaneous Deep Fungal Infections: Retrospective at a Tertiary Care Cancer Center, 2022. e-Pub 2022.
Cho WC, Ding Q, Wang WL, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Albarracin CA, Sahin A, Prieto VG, Aung P. TRPS1 Expression is Frequently Seen in Mammary and Extramammary Paget Diseases, Except for Those Arising in the Perianal Skin, 2022. e-Pub 2022.
Gill P, Milton DR, Ballester LY, Cho WC, Nagarajan P, Curry JL, Ivan D, Prieto VG, Davies M, Torres-Cabala CA, Aung P. Characterizing the Clinicopathologic and Molecular Landscape of Acral Lentiginous Melanoma: A Retrospective Review of 331 Patients, 2022. e-Pub 2022.
Nagarajan P, Gleber-Netto F, Parra E, Pickering C, Davies M, Aung P, Cho WC, Torres-Cabala CA, Curry JL, Ivan D, Prieto VG, Pettaway C. Exploratory Analyses of Tumor-Infiltrating Inflammatory Cells in Male Genitourinary Melanoma, 2022. e-Pub 2022.
Lazcano, R, Hernandez S, Mehta J, Cho WC, Parra E, Solis Soto L, Casavilca Z, Castillo M, Castaneda C, Nagarajan P, Curry JL, Wistuba I, Prieto VG, Aung P, Torres-Cabala CA. PD-L1 Expression by Tumor-Associated Macrophages (TAMS) of M2 Subtype is Associated with Overall Survival in Acral Lentiginous of Different Ethnicities, 2022. e-Pub 2022.
Ronen S, Billings S, Mcniff J, Torres-Cabala CA, George S, Heberton M, Thomas V, Aung P, Curry JL, Cho WC, Ivan D, Prieto VG, Nagarajan P. Extramammary Post-Radiation Atypical Vascular Lesions: A Clinicopathologic Study of Eight Cases, 2022. e-Pub 2022.
Vanderbeck K, Milton D, Nagarajan P, Rothrock A, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung P, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung P, Cho WC. SOX11 Serves as an Effective Discriminatory Marker, When Used in Conjunction with CK20 and TTF1, for Merkel Cell Carcinoma: A Comparative Analysis of SOX11, CK20, PAX5 and TTF1 Expressions in Merkel Cell Carcinomas and Pulmonary Small Cell Carcinomas, 2022. e-Pub 2022.
Rothrock A, Cho WC, Nagarajan P, Curry JL, Vanderbeck K, Ivan D, Prieto VG, Torres-Cabala CA, Aung P. Diagnostic Utility of PRAME Immunohistochemistry in Subungual and Acral Melanocytic Lesions, 2022. e-Pub 2022.
Piubelli MLM, Tetzlaff MT, Nagarajan P, Nelson K, Duke T, Glitza IC, Ledesma D, Torres-Cabala CA, Wistuba I, Prieto VG, Curry JL. Hypertrophic lichenoid dermatitis immune-related adverse event from combined immune checkpoint and exportin inhibitor therapy: A histologic diagnostic pitfall for superficially invasive squamous cell carcinoma, 2019. e-Pub 2019.
Welborn ME, Duke T, Damodaran S, Prieto VG, Nagarajan P, Torres-Cabala CA, Curry JL, Migden M, Doan HQ. Combination immnotherapy with nivolumab and NKTR-214 induced atypical erythematous squamous epithelial eruptions, 2019. e-Pub 2019.
Aung PP, Milton DR, Ivan D, Pradhan D, Nagarajan P, Tetzlaff MT, JL &, Wen-Jen H, Prieto VG, Torres-Cabala CA. Acral lentiginous subtype is an indicator of worse survival in early stage (T1) melanoma, 2019. e-Pub 2019.
Aung PP, Parra ER, Barua S, Sui D, Mino B, Curry JL, Nagarajan P, Torres-Cabala CA, Lazar AJ, Rao A, Wistuba I, Prieto VG, Tetzlaff MT. B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density, 2019. e-Pub 2019.
Pradhan D, Malpica A, Prieto VG, Curry JL, Torres-Cabala CA, Ivan D, Aung PP, Gershenwald JE, Davies MA, Tetzlaff MT, Nagarajan P. Primary Mucosal Melanoma of the Uterine Cervix: Clinicopathological and Molecular Analysis, 2019. e-Pub 2019.
Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Aung PP, Ivan D, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic Model for Disease Specific Survival in Anorectal Melanoma, 2019. e-Pub 2019.
Ronen S, Prieto VG, Yildiz P, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Metastatic Carcinoma Involving the Periareolar Skin. A Surprise, 2018. e-Pub 2018.
Nagarajan P, Pettaway C, Davies M, Bassett Jr R, Haydu L, Li R, Jones A, Tamboli P, Curry JL, Torres-Cabala CA, Ivan D, Aung PP, Gershenwald J, Prieto VG, Tetzlaff MT. Tumor Thickness Correlates with Regional Metastasis in Male Genitourinary Melanoma, 2018. e-Pub 2018.
Messer A, Huen A, Cataldo V, Curry JL, Nagarajan P. Multifocal Primary Cutaneous Mucinous Adenocarcinoma, 2018. e-Pub 2018.
Pradhan D, Khoury J, Aung PP, Tetzlaff MT, Torres-Cabala CA, Curry JL, Ivan D, Prieto VG, Nagarajan P. Coincident Merkel Cell Carcinoma And Mantle Cell Lymphoma, 2018. e-Pub 2018.
Erstine E, Nagarajan P, Aung PP, Curry JL, Euscher E, Ivan D, Schwartz M, Tetzlaff MT, Torres-Cabala CA, Prieto VG. PAX8-positive Mucosal Melanoma Arising in the Female Genitourinary Tract, 2018. e-Pub 2018.
Ronen S, Torres-Cabala CA, George SJ, Aung PP, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Nagarajan P. Bilateral Atypical Vascular Lesion Arising in the Setting of Radiation Therapy for Head and Neck Squamous Cell Carcinoma, 2018. e-Pub 2018.
Arudra SK, Aung P, Tetzlaff MT, Curry JL, Nagarajan P, Ivan D, Prieto VG, Hwu WJ, Torres-Cabala CA. A Dual PD-L1/SOX-10 Immunhistochemical Study Combined With Digital Imaging Enhances Accuracy In Stratifying Metastatic Melanoma Patients For Immune Checkpoint Therapy, 2018. e-Pub 2018.
Aung P, Ivan D, Milton D, Nagarajan P, Tetzlaff MT, Curry JL, Prieto VG, Hwu WJ, Torres-Cabala CA. Is Subungual Location a Prognostic Factor for Acral Lentiginous Melanoma?, 2018. e-Pub 2018.
Farah M, Nelson K, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Ivan D, Prieto VG, Curry JL, Aung PP. Lichen Planus Related to Transforming Growth Factor Beta Inhibitor in a Patient with Metastatic Chondrosarcoma, 2018. e-Pub 2018.
Farah M, Denai M, Gu J, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Aung PP. Histologic Features Predictive of Metastasis and Survival in 230 Patients with Cutaneous Squamous Cell Carcinoma (cSCC) from Head and Neck and non-Head and Neck Locations, 2018. e-Pub 2018.
Pradhan D Ivan D, Nelson K, Torres-Cabala CA, Tetzlaff MT, Curry JL, Nagarajan P, Prieto VG, Aung PP. "Melanocarcinoma," a Rare But Diagnostic Pitfall, 2018. e-Pub 2018.
Pradhan D, Arudra SK, Prieto VG, Ballester L, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Luthra R, Aung PP. Next-Generation Sequencing-Based Molecular Characterization of Histophenotypic Plasticity in Primary and Metastatic Melanoma, 2018. e-Pub 2018.
Nagarajan P, Piao J, Ning J, Curry JL, Torres-Cabala CA, Aung PP, Wang WL, Ross MI, Royal RE, Wargo JA, Rashid A, Samdani R, Noordenbos LE, Lazar AJ, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Stage at presentation determines associations between histologic parameters of primary tumor and disease specific survival (DDS) in anorectal melanoma (AM), 2018. e-Pub 2018.
Trinidad CM, Nelson KC, Glitza Olivia IC, Torres-Cabala CA, Curry JL, Nagarajan P, Tetzlaff MT, Ivan D, Hwu WJ, Prieto VG, Aung P. Interstitial granulomatous dermatitis: a novel toxicity from immune checkpoint blockade therapy 40(5):e73, 2018. e-Pub 2018.
Trinidad CM, Tetzlaff MT, Ivan D, Nagarajan P, Torres-Cabala CA, Curry JL, Prieto VG, Aung PP. Expression of neuroendocrine markers in sebaceous carcinoma: A potential diagnostic pitfall 31(S2):212, 2018. e-Pub 2018.
Trinidad CM, Hawkins M, Prieto VG, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Recurrent/Persistent Nevus: A Clinical and Histologic Evaluation of Features Associated With Recurrence and Persistence of Melanocytic Nevi 31(S2):212, 2018. e-Pub 2018.
Aung P, Barua S, Mino B, Curry JL, Nagarajan P, Torres-Cabala CA, Lazar A, Rao A, Wistuba I, Prieto VG, Tetzlaff MT. Multiplex Immunofluorescence (mIF) and Novel Computational Method Demonstrates Co-expression of B7-H3 in Tumor-associated CD31+ Endothelium of Merkel Cell Carcinoma (MCC) 31(S2):213, 2018. e-Pub 2018.
Yildiz P, Ivan D, Aung P, Curry JL, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Prieto VG. The Prognostic Impact of Tumor Thickness by Using Different Measurement methods in Cutaneous Squamous Cell Carcinomas 31(S2):213, 2018. e-Pub 2018.
Nagarajan P, Piao J, Ning J, Samdani R, Noordenbos LE, Curry JL, Torres-Cabala CA, Aung PP, Ivan D, Wang WL, Ross MI, Royal RE, Rashid A, Lazar AJ, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Primary anorectal melanoma: Distinct histopathologic parameters of the primary tumor correlate with disease specific survival (DSS) depending upon the stage at presentation 31(S2):204, 2018. e-Pub 2018.
Aung P, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Malnoma with Loss of BAP1 Expression in Patients with No Family History of BAP1-Associated Cancer Susceptibility Syndrome 31(S2):193, 2018. e-Pub 2018.
Arudra SKC, Ivan D, Chen WS, Nagarajan P, Curry JL, Torres-Cabala CA, Tetzlaff MT, Prieto VG. Destaining-Restaining Immunostudies Combined With Whole-Slide Scanning: A Helpful Tool in Dermatopathology 31(S2):765, 2018. e-Pub 2018.
Al-Rohil RA, Jour G, Nagarajan P, Aung PA, Tetzlaff MT, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG. Discordances in Evaluation of Melanocytic Lesions and Its Impact on Management: A Study of 1518 Cases 30(S2):501A, 2017. e-Pub 2017.
Van Arnam J, Curry JL, Nagarajan P, Aung PA, Lazar AJ, Prieto VG, Esmaeli B, Tetzlaff MT. PD-L1 Expression in Sebaceous Carcinoma of the Eyelid Implicates the Utility of Immune Checkpoint Blockade 30(S2):438A, 2017. e-Pub 2017.
Samdani R, Tetzlaff MT, Curry JL, Ning J, Piao J, Aung PA, Torres-Cabala CA, Ivan D, Wang WL, Lazar A, Ross MI, Royal RE, Wargo JA, Gershenwald JE, Davies MA, Prieto VG, Rashid A, Nagarajan P. Primary Anorectal Melanoma: A Retrospective Analysis of 30 Patients 30(S2):135A, 2017. e-Pub 2017.
Mauzo SH, Prieto VG, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Torres-Cabala, Aung PA. Expression of PD-L1 in Extramammary Paget disease: Implications for Immune-targeted Therapy 30(S2):134A, 2017. e-Pub 2017.
Siroy AE, Sui D, Ning J, Luthra R, Patel KP, Routbourt MJ, Broaddus RR, Nagarajan P, Aung PP, Ivan D, Curry JL, Torres-Cabala CA, Prieto VG, Davies MA, Lazar AJ, Tetzlaff MT. An Assessment of Copy Number Variations and Somatic Mutations in Advanced Melanomas by Clinical Next-Generation Sequencing 30(S2):136A, 2017. e-Pub 2017.
Curry, JL, Tetzlaff MT, Reuben A, al E. Gene expression profiling of dermatologic toxicities from immune checkpoint therapy, 2017. e-Pub 2017.
Al-Rohil R, Feldmeyer L, Nagarajan P, Lyons G, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Malpica A, Tetzlaff MT. Intratumoral Lymphovascular Invasion Detected by D2-40 Correlates with Metastasis in Primary Cutaneous Merkel Cell Carcinoma 29(2s):125A, 2016. e-Pub 2016.
Wimmer D, Tetzlaff MT, Torres-Cabala CA, Milton DR, Nagarajan P, Aung P, Prieto VG, Curry JL. Immunodetection of mitotic figures and G2+ tumor nuclei with histone markers in stage III melanoma samples 29(2s):138A, 2016. e-Pub 2016.
Nagarajan P, Curry JL, Ning J, Piao J, Aung PP, Ivan D, Torres-Cabala CA, Prieto VG, Malpica A, Tetzlaff MT. Melanomas of the Vulva: A Retrospective Analysis of Clinical and Histopathologic Parameters in 40 Patients 29(2s):134A, 2016. e-Pub 2016.
Aung PP, Ravishankar S, Friedman KA, Milton D, Curry JL, Torres-Cabala CA, Ivan D, Tetzlaff MT, Gershenwald JE, Prieto VG, Nagarajan P. Prognostic Significance of Regression in Patients with Thin Primary Cutaneous Melanoma 29(2s):126A, 2016. e-Pub 2016.
Curry JL, Aung PP, Nagarajan P. The composition, density, and location of immune infiltrates correlate with survival in Merkel cell carcinoma 29(2s):126A, 2016. e-Pub 2016.
Curry, JL, Tetzlaff MT, Torres-Cabala C. Clinical and Histologic Patterns of Dermatologic Toxicity from Immune Checkpoint Blockade Therapy, 2016. e-Pub 2016.
Tetzlaff MT, Curry JL, Manyam GC, Wani K, Yin VT, Aldape K, Prieto VG, Esmaeli B. Differentially Expressed miRNAs Implicate Pathways in the Genesis of Sebaceous Carcinomas and Adenomas, 2015. e-Pub 2015.
Al-Rohil RN, Curry JL, Torres-Cabala CA, Ivan D, Bassett RL, Prieto VG, Tetzlaff MT. Diagnosing ambiguous melanocytic tumors in a tertiary referral center: the contribution of second generation fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses, 2015. e-Pub 2015.
Danialan R, Kudakwashe M, Curry JL, Torres-Cabala CA, Ivan D, Nagarajan P, Aung PP, Prieto VG, Tetzlaff MT. The impact of second-opinion pathologic review on melanoma management at a tertiary cancer referral center, 2015. e-Pub 2015.
Mudaliar K, Torres-Cabala CA, Tetzlaff MT, Duvic M, Ciurea A, Hymes S, Tsai KY, Prieto VG, Curry JL. Vemurafenib associated melanocytic lesions lack BRAFV600E mutation and show preserved BAP1 expression, 2015. e-Pub 2015.
Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox P, Patel K, Estrella J, Broaddus R, Davies MA, Routbort M, Lazar A, Prieto V, Hwu WJ, Gershenwald J, Woodman S, Torres-Cabala C, Curry JL. Utility of BRAFV600E immunohistochemistry expression pattern as a surrogate of BRAFV600 mutation status in 154 patients with advanced stage melanoma, 2015. e-Pub 2015.
Henderson SA, Torres-Cabala CA, Curry JL, Bassett R, Ivan D, Prieto VG, Tetzlaff MT. p40 improves diagnostic specificity between Atypical Fibroxanthoma and poorly differentiated Squamous Cell Carcinoma compared to p63, 2014. e-Pub 2014.
De la Garza Bravo MM, Curry JL, Torres-Cabala CA, Ivan DS, Drucker C, Prieto VG, Tetzlaff MT. Shared Clonality in Distinctive Lesions of Lymphomatoid Papulosis and Mycosis Fungoides Occurring in the Same Patients Suggests a Common Origin, 2014. e-Pub 2014.
Henderson SA, Tetzlaff MT, Pattanaprichakul P, Curry JL. Immunohistochemistry for Histone H3K79me3T80ph Is Superior to PHH3 in the Detection of Mitotic Chromatin and G2 Positive Nuclei in Merkel Cell Carcinoma, 2014. e-Pub 2014.
Danialan R, Tetzlaff MT, Torres-Cabala CA, Mays SR, Prieto VG, Bell D, Curry JL. Cutaneous Metastasis from Anaplastic Thyroid Carcinoma with Spindle Cell Morphology: A rare entity in the histologic differential of spindle cell malignancies in the skin, 2014. e-Pub 2014.
Loghavi S, Curry JL, Torres-Cabala. Tumor size correlates with survival in melanomas associated with conventional or cellular blue nevi or displaying blue nevus-like features (so called malignant blue nevus), 2014. e-Pub 2014.
Pattanaprichakul P, Casavilca S, Tetzlaff MT, Curry JL. Primary Acral Lentiginous Melanoma in Patients with Non-Caucasian Ethnicities from East Asia and Latin American Demonstrates Frequent Heterogenous Immunodetection of BRAFV600E and Preserved PTEN Protein Expression, 2014. e-Pub 2014.
Stockman D, Broaddus R, Lazar AJ, Curry JL. Melanoma with synchronous SMARCB1 and BRAF or TP53 mutations: a histologic, immunohistochemical and molecular analysis, 2014. e-Pub 2014.
Lee N, Duvic M, Curry J, Torres-Cabala C. Plasmacytoid Dendritic Cell Neoplasm in a Patient with a 10-Year History of Pruritus 35(5):e96, 2013. e-Pub 2013.
Tetzlaff MT, Curry JL, Stockman DL, Ivan D, W-L W, Valencia KM, Bassett R, Torres-Cabala CA, Prieto VG. Immunodetection of Phosphohistone H3 (PHH3) as a Surrogate of Mitotic Figure Count and Clinical Outcome in Cutaneous Melanoma 93(Suppl 1):123A, 2013. e-Pub 2013.
Agarwal A, Torres-Cabala CA, Tetzlaff MT, Stockman DL, Chu V, Prieto VG, Curry JL. The Impact on Final Breslow Thickness and Sentinel Lymph Node Status with Initial Biopsies of Cutaneous Melanomas Transected at the Base 93(Suppl 1):110A, 2013. e-Pub 2013.
Kapil JP, Chakravarti N, Curry JL, W-L W, Prieto VG, Tetzlaff MT, Torres-Cabala CA. Evaluation of Fumarate Hydratase and Hypoxia-Associated Proteins in HLRCC Syndrome and Sporadic Cutaneous Leiomyomas 93(Suppl 1):115A-116A, 2013. e-Pub 2013.
Milless TL, Curry JL, Torres-Cabala CA, W-L W, McLemore MS, Ivan D, Prieto VG, Tetzlaff MT. Diagnosing Ambiguous Melanocytic Tumors in a Tertiary Referral Center: The Contribution of Fluorescence In Situ Hybridization (FISH) to Conventional Histopathologic and Immunophenotypic Analyses 93(Suppl 1):478A, 2013. e-Pub 2013.
Lee N, Curry JL, Duvic M. Blastic plasmacytoid dendritic cel neoplasm (BPDCN) shows frequent association with acute myeloid leukemia (AML): a single institution experience, 2013. e-Pub 2013.
Pattanaprichakul P, Tetzlaff MT, Torres-Cabla CA, Curry JL. Malignant neurocristic hammartoma with EWSR1 gene rearrangement detected by fluorescent in situ hybridization (FISH), 2013. e-Pub 2013.
De la Garza Bravo M, Curry JL, Prieto VG. Pigmented extramammary Paget disease of the thigh mimicking a melanocytic nevus: a diagnostic pitfall, 2013. e-Pub 2013.
Rose CL, Curry JL, Torres-Cabala CA, Chakravarti N, Prieto VG, Tetzlaff MT. The Utility of ATF3 in Cutaneous Epithelial Neoplasms 25(Suppl 2):132A-132a, 2012. e-Pub 2012.
Syklawer EE, Jakob J, Bassett RL, Gershenwald JE, Prieto VG, Curry JL, Davies MA, Lazar AJ. Clinical Correlates of Specific BRAF and NRAS Mutations in Melanoma 25(Suppl 2):135A-135A, 2012. e-Pub 2012.
Chu VH, Tetzlaff MT, Prieto VG, Torres-Cabala C, Bassett R, McLemore MS, Ivan D, W-L W, Curry JL. Implications of the 2009 AJCC Melanoma Staging and Classification System for Thin Melanomas 25(Suppl 2):117A-118A, 2012. e-Pub 2012.
Curry J, Aung P, Patel K, Prieto V, Duvic M, Torres-Cabala C. Immunophenotypic Shift in Mycosis Fungoides: A case report and review of the literature 39:182-183, 2012. e-Pub 2012.
Curry C, Chu V, Schneider M, Curry J. Mycobacterium Avium-Intracellulare Complex Skin Infection in an HIV-Negative Patient with Idiopathic CD4+ Lymphocytopenia 39:106, 2012. e-Pub 2012.
Curry J, Schneider M, Joseph J, Finch C, Elghetany T, Sheehan A, Curry C. Disseminated Cutaneous Manifestaton of Plasmablastic Lymphoma: A rare case presentation 39:193, 2012. e-Pub 2012.
Curry J, McQuitty E, Tetzlaff M, Prieto V, Duvic M, Torres-Cabala C. CD8-Positive CD30-Positive Lymphomatoid Papulosis and Its Differential Diagnosis: A review of 20 cases 39:99, 2012. e-Pub 2012.
Torres-Cabala CA, Li-Ning-Tapia EM, Ramos C, Curry JL, Prieto VG, Miranda RN, Bravo F. Expression of FoxP3 in HTLV-1-associated infective dermatitis syndrome 24(Suppl 1):126A-126A, 2011. e-Pub 2011.
Li-Ning-Tapia EM, Curry J, Zhang P, Prieto VG, Torres-Cabala CA. Epigenetics markers in acral lentiginous/mucosal melanoma: expression of EZH2 91(Suppl 1):119A-120A, 2011. e-Pub 2011.
Torres-Cabala CA, Li-Ning-Tapia EML, Ramos C, Curry JL, Prieto VG, Bravo F. Evidence of regulatory T-cell immunophenotype in a subset of HTLV-1 associated infective dermatitis: an early sign of progression? 23(Suppl 1):123A-123A, 2010. e-Pub 2010.
Li-Ning-Tapia EML, Wang WL, Curry JL, Prieto VG, Torres-Cabala CA. Expression of p16 and MITF-1 in acral lentiginous/mucosal melanomas 23(Suppl 1):119A-119A, 2010. e-Pub 2010.
LeLeux T, Curry J, Reed J, Lopez-Terrada D, Hernandez V. BRAF(V600E) mutation induction of p16INK4a and p57KIP2 expression in recurrent nevi 36:110-111, 2009. e-Pub 2009.
Curry J, Huttenbach Y, Richards H, Lin Q, Chen D, Reed J. Different expression patterns of p27KIP1 and p57KIP2 protein in benign and malignant melanocytic neoplasms 35:140-141, 2008. e-Pub 2008.
Curry J, Nickoloff B, Marble D, Cimino V, Vejabhuti C. Pacinian stromal cell tumor: a distinctive CD34 positive peripheral nerve sheath tumor of pacinian corpuscles 34:111-112, 2007. e-Pub 2007.
Hofmeister CC, Peterson A, Kroll T, Stiff P, Curry J, Nickoloff BJ. Epidermal dendritic cell depletion with myeloablative conditioning that does not recover post transplant 12(Issue 2, Suppl 1):52, 2006. e-Pub 2006.
V Gasilionis V, A Salhadar A, JA Reed JA, BJ Nickoloff BJ, JL Curry JL. Giant cell fibroblastoma with unusual histologic features 33:84, 2006. e-Pub 2006.
Curry JL, Reed JA. Expression of KROX-20 is increased in psoriasis 32:83-4, 2005. e-Pub 2005.
Qin J, Curry JL, Robinson J, Nickoloff BJ. Role for heat shock proteins and innate immune response in psoriasis 119(1, Part 2):300-300, 2002. e-Pub 2002.
Curry JL, Herrmann M, Wojcik EM. The effects of the current WHO/ISUP bladder neoplasms classification system on urine cytology results 81(1):106A-106A, 2001. e-Pub 2001.
Curry JL, Hsi ED, Sandin R, Nickoloff BJ, Alkan S. Detection of human herpes virus-6 (HHV-6) in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) 11(1):128A-128A, 1998. e-Pub 1998.

Book Chapters

Nguyen, CV, Curry JL, Chu EY. Cutaneous Toxicities of Drugs. In: Lever's Dermatopathology: Histology of the Skin. 12. Lippincott Williams & Wilkins (LWW), 2023.
Torres Cabala, CA, Tetzlaff, M, Nagarajan, P, Ivan, D, Curry, JL, Aung, PP, Prieto, V. Skin, 3-227, 2020.
Nagarajan P, Tetzlaff MT, Curry JL. Histopathology of Basal Cell Carcinoma and Its Variants. In: In Basal Cell Carcinoma: Advances in Research and Treatment. Springer, Cham, 25-48, 2020.
Curry JL. "Cutaneous Drug Eruptions". In: Barnhill's Dermatopathology. 4th. McGraw Hill, 2019.
Curry JL. "Melanocytic Proliferations". In: Oncologic Surgical Pathology. Springer, 2019.
Torres Cabala, CA, Aung, PP, Miranda, R, Curry, JL. Immunohistology and molecular studies of cutaneous t-cell lymphomas and mimics, 229-259, 2016.
Curry JL, Prieto VG. Melanoma. In: Encyclopedia of Pathology. 1st. Springer-Verlag, 2016.
Curry JL, Torres-Cabala CA, Prieto, VG. Histopathology of nonmelanoma skin cancer. In: Cutaneous Malignancy of the Head and Neck: A Multidisciplinary Approach. Plural Publishing, Inc, 2011.
Curry JL, Nickoloff BJ. Experimental Chimeric SCID Mouse/Human Skin Model Passive Transfer. In: Animal Model of Human Skin Diseases. CRC Press LLC, 2004.
Curry J, Amin HM, Theil KS. Synovial, Pleural, and Peritoneal Fluids. In: Clinical Laboratory Medicine. 2nd. Lippincott Williams & Wilkins, 2002.

Books (edited and written)

Curry, JL, Tetzlaff, M, Nagarajan, P, Torres Cabala, CA. Immunohistology of melanocytic lesions, 2016.
Torres-Cabala CA, Curry JL. Genetics of Melanoma. Springer, 2016.
Curry, JL, Nickoloff, BJ. Experimental chimeric SCID mouse/human skin model of psoriasis, 2003.
McClatchey KD, Curry JL, Amin HM. Clinical Laboratory Medicine. Self Assessment and Review. Lippincott Williams & Wilkins, 2002.

Letters to the Editor

Torres Cabala, CA, Yescas, JA, Zhang, Y, Huen, A, Sumit, G, Tefft, K, Tang, G, Curry, JL, Gunther, J, Dabaja, BS, Iyer, S, Miranda, R, Choi, J, Nardi, V. Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel FGFR1 fusion treated with pemigatinib. Blood Advances 9: 1786-1790, 2025.
Ibrahim, E, Yang, RK, Curry, JL, Cho, WC. BCR::ZNF711 and BCR::CYLC2 Fusions: Novel BCR Fusions Expanding the Molecular Spectrum of Gene Fusions in Melanoma. American Journal of Dermatopathology 46: 797-799, 2024.
Chu VH, Curry JL, Elghetany MT, Curry CV. MonoMAC versus idiopathic CD4+ lymphocytopenia. Comment to Haematologica. 2011;96(8):1221-5. Haematologica 97: e9-e11, 2012.